WO2006068001A1 - Hydrolyzed-silk-containing composition for oral cavity - Google Patents

Hydrolyzed-silk-containing composition for oral cavity Download PDF

Info

Publication number
WO2006068001A1
WO2006068001A1 PCT/JP2005/022831 JP2005022831W WO2006068001A1 WO 2006068001 A1 WO2006068001 A1 WO 2006068001A1 JP 2005022831 W JP2005022831 W JP 2005022831W WO 2006068001 A1 WO2006068001 A1 WO 2006068001A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition
silk
sodium
molecular weight
average molecular
Prior art date
Application number
PCT/JP2005/022831
Other languages
French (fr)
Japanese (ja)
Inventor
Yasushi Fukuda
Kouichi Saito
Original Assignee
Lion Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lion Corporation filed Critical Lion Corporation
Priority to KR1020077013828A priority Critical patent/KR101293893B1/en
Priority to JP2006548846A priority patent/JP4826790B2/en
Priority to CN2005800463591A priority patent/CN101098676B/en
Publication of WO2006068001A1 publication Critical patent/WO2006068001A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20Halogens; Compounds thereof
    • A61K8/21Fluorides; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses

Definitions

  • the present invention coats teeth with hydrolyzed silk having a high ability to adsorb teeth to dentin, thereby effectively protecting the teeth from fungal acid, enzymes, etc. that cause caries.
  • the present invention also relates to a composition for oral cavity in which the retention of fluorine and antibacterial agents is improved, and the dental caries preventive effect is dramatically improved by remarkably preventing dissolution and decomposition of the dentin. . Background art
  • dentin has a structure that is more porous and rich in organic matter than enamel, and most of the organic matter is type I collagen.
  • the onset mechanism of dentin caries is as follows. First, plaque adheres to the dentin surface, and sugars are metabolized by bacteria in the plaque to produce acid. The acid elutes (mineralizes) dentin minerals, exposing collagen. Furthermore, collagen is degraded by collagenase derived from bacteria and saliva to form an axilla (dent). Dentin caries progress to deeper depth and caries by repeated decalcification and collagen decomposition. For these reasons, it is important to effectively suppress both demineralization and collagen degradation in order to improve the effect of preventing dentin caries.
  • Mouthwash containing collagen or gelatin exhibits high adsorbability to type II collagen contained in the vitreous body and cartilage of the eye, while dentin, bone, and oral mucosa Adsorption of the composition to the teeth has a big problem because it has a small adsorption ability for type I collagen contained in the tooth.
  • the tooth surface coating agent containing fatty acid salt Japanese Patent Laid-Open No. 2000-103726
  • tooth acid resistance enhancing composition (Japanese Patent Laid-Open No. 6-298632) composed of tea polyphenol, fluorine and aluminum salt has a bad taste and can be effective in the acidic region. Under normal use, such as a mouthwash, an insoluble precipitate is formed between fluorine and aluminum ions in the vicinity of neutral pH, and in the case of a dentifrice, and also with an abrasive. The effect of improving the incorporation into the tooth is not expected.
  • composition for oral cavity composed of sinoretafive mouth-in (Japanese Patent Laid-Open No. 2001-226242) is not hydrolyzed silk as in Japanese Patent Laid-Open No. 2003-113072, so the number average molecular weight of fibrin is about 350 Although it has excellent film-forming protection effects on mucous membranes such as ⁇ 000, which have a large tongue, the effect on the tooth surface is inferior because of its low adsorption effect on hard teeth.
  • naturally-occurring polypeptide compounds are more permeable and more adsorbable as the molecular weight is smaller, while the lower the film-forming property and the larger the molecular weight, the lower the adsorptivity and permeability, while the film-forming performance is improved. It is said.
  • the adsorptivity and penetrability of collagen polypeptides to hair are molecular weight, and the higher the molecular weight, the greater the film-forming property. While improving the adsorptive 'permeability There is a decline.
  • An object of the present invention is to solve the above-mentioned problems and to provide a composition for oral cavity having a high effect of preventing dentine caries in a short time treatment.
  • the inventors of the present invention have developed a peptide complex obtained by further hydrolyzing a sinoretive mouth-in obtained by refining silk yarn with an acid, an alkali, an enzyme, and the like.
  • a sinoretive mouth-in obtained by refining silk yarn with an acid, an alkali, an enzyme, and the like.
  • the ability to inhibit collagen degradation and the ability to suppress decalcification are further improved by providing a poorly water-soluble nonionic antibacterial agent, and the present invention has been completed.
  • An oral composition comprising hydrolyzed silk having a number average molecular weight of 200 to 6,000 calculated based on the total nitrogen content and amino nitrogen content, and a fluorine compound,
  • the amount of hydrolyzed silk is 0.:! To 10% by mass of the entire composition, and the amount of fluorinated compound is 0.02 to 3% by mass of the entire composition [I] or [ II] oral cavity composition,
  • the poorly water-soluble nonionic antibacterial agent is triclosan or isopropylmethylphenol
  • the surfactant is polyoxyethylene hydrogenated castor oil or alkyl sulfate ester salt having an average added mole number of 5 to 100.
  • the amount of the poorly water-soluble nonionic antibacterial agent is 0.0 :! to 2% by mass of the whole composition, and the amount of the surfactant is 0.0.% To 5% by mass of the whole composition
  • the composition for oral cavity according to [IV] or [V] is provided, wherein the blending amount of alcohol is 0.:! To 50% by mass of the entire composition.
  • composition for oral cavity of the present invention is characterized by containing hydrolyzed synolec.
  • the hydrolyzed silk can be obtained by hydrolyzing silk fibroin obtained by refining the silk thread spun from the silkworm with an acid, alkali, enzyme or the like.
  • a silk thread has a five mouth-in in the center and sericin in the periphery.
  • silk thread As for silk thread, first, silkworms produced by a sericulture farmer are dried and boiled to produce raw silk, and then raw silk is scoured to obtain silk thread or silk fabric.
  • the most common method of boiling is a method of boiling in an aqueous solution containing alkaline sodium salt gypsum (alkaline stone koji), which removes sericin on the outside of the silk thread, Purified by mouth-in only.
  • Hydrolyzed silk can be obtained by hydrolyzing this hive mouth-in (average molecular weight: about 350,000) with acid 'alkali, enzyme, etc., but depending on the degree of hydrolysis, Various molecular weights can be prepared. In the case of the present invention, hydrolyzed silk obtained by phosphoric acid hydrolysis is particularly preferred.
  • the hydrolyzed silk used in the present invention has a number average molecular weight of 200 to 6,000, preferably a f of 500 to 5,000, more preferably a clay of 500 to 1,000. If the number average molecular weight is less than 200, there is adsorptivity to teeth, but the film-forming property is extremely low, and if it exceeds 6,000, the film-forming property is high, but the adsorptivity decreases. The effect is reduced. Hydrolyzed synolec is available from various companies in grades with various number average molecular weights, and they can be used as needed.
  • the number average molecular weight can generally be calculated by gel filtration chromatography (GPC) and calculation of analytical nitrogen value.
  • GPC gel filtration chromatography
  • a polypeptide such as hydrolyzed silk can be used. The latter is often used for compounds.
  • the number average molecular weight of the hydrolyzed silk of the present invention is calculated by the following formula (1) based on the total nitrogen amount in the molecule, the amino nitrogen amount, and the average molecular weight of the constituent amino acids.
  • the average molecular weight of the constituent amino acids is obtained by multiplying the abundance ratio (%) of constituent amino acids obtained by ordinary amino acid analysis by the molecular weight of each amino acid, and the total nitrogen amount is
  • the first nitrogen determination method of the cosmetic raw material standard general test method or gas chromatography (GC) the amount of amino nitrogen can be measured by a formol titration method.
  • the amount of the hydrolyzed synolec is not particularly limited. 0.1 to 10% (percentage by mass, the same shall apply hereinafter) is preferable, and 0.5 to 5% is particularly desirable. When the content is lower than 0.1%, the effect of the present invention cannot be sufficiently obtained. When the content exceeds 10%, the taste and feeling of use may be deteriorated.
  • the oral composition of the present invention contains a fluorine compound.
  • the fluorinated compound used in the present invention include sodium fluoride, sodium monofluorophosphate, stannous fluoride and the like, and sodium fluoride and sodium monofluorophosphate are particularly preferred. From the viewpoint of caries prevention, it is preferable to add these fluorine compounds in an amount of 0.02 to 3% of the whole composition, particularly in the case of Futsui sodium, more preferably 0.0 to 1% of the whole composition. Is 0.02 to 0.7%, and in the case of sodium monofluorophosphate, it is preferably 0.05 to 3%, more preferably 0.07 to 2.5% of the total composition.
  • Difficult water-soluble nonionic antibacterial agents include triclosan (water solubility; 0.001 g / l00 mL (20 ° C), the value listed on the Ministry of the Environment website), isopropylmethylphenol (same; 0 ⁇ 015 g / 10 0 mL (25 ° C), Osaka Kasei Co., Ltd. catalog value), thymol (same; 0 ⁇ 098g / 100mL (25 ° C), Osaka Kasei Co., Ltd.
  • Examples include nonionic antibacterial agents having a solubility of 0 ⁇ lg / lOOmL or less, among which triclosan and isopropylmethylphenol are preferable.
  • one or two or more of the poorly water-soluble nonionic antibacterial agents can be used in combination.
  • the blending amount is preferably 0.001 to 2% force S of the whole composition, more preferably 0.01 to 1%. If it is less than 001%, the sufficient bactericidal effect may not be exhibited, and if it exceeds 2%, solubilization in the preparation may be difficult, and the taste and usability may be deteriorated.
  • a surfactant can be added to the oral composition of the present invention in order to improve the solubility of the poorly water-soluble nonionic antibacterial agent and oil-soluble fragrance.
  • surfactants polyoxyethylene hydrogenated castor oil and alkyl sulfate esters are preferred.
  • Polyoxyethylene hydrogenated castor oil has an average added mole number of ethylene oxide of 5 to 100. Especially, 5 to 20 for dentifrice and 40 to 100 for mouthwash are preferred. ,. If the average number of added moles is less than 5, oil solubility increases and foaming power decreases, and if it exceeds 100, stability of the poorly water-soluble nonionic antibacterial agent may decrease.
  • the amount of castor oil blended is preferably 0.1-5% of the composition, especially 0.5-2.5% for dentifrice and 0.2-2% for mouthwash. is there. If it is less than 1%, the stabilizing effect of the poorly water-soluble nonionic antibacterial agent cannot be obtained sufficiently, and if it exceeds 5%, sufficient foaming power may not be obtained.
  • alkyl sulfate ester salts examples include alkali metal salts such as sodium, potassium, lithium and the like such as octyl sulfate, decyl sulfate, lauryl sulfate, myristyl sulfate, palmityl sulfate, stearyl sulfate, etc. Sodium lauryl sulfate is most preferred.
  • the blending amount of the alkyl sulfate ester salt is preferably 0.05 to 5%, and more preferably 0.5 to 2.5 for a dentifrice. / 0, in the case of mouthwashes is preferably 0.:! ⁇ 0.5%. If it is less than 0.05%, sufficient foaming property cannot be obtained, and if it exceeds 5%, foaming property is strong and the feeling of use may be lowered.
  • alcohols can be blended in place of the surfactant or together with the surfactant.
  • the alcohol one or more of propylene glycol, polyethylene glycol (# 200 to 6000), ethylene glycol, glycerin, sonorebitol, ethanol and the like can be used, and the blending amount is 0.:! To 50 of the entire composition. % Is more preferably 1 to 40%. When the content is less than 0.1%, a poorly water-soluble nonionic antibacterial agent may not be stably blended, and when it exceeds 50%, the taste and usability may be deteriorated.
  • inorganic calcium compounds such as calcium chloride, calcium nitrate, calcium sulfate, calcium glycephosphate, calcium hydroxide, and calcium lactate
  • organic calcium compounds such as calcium acetate, calcium malonate, calcium citrate, calcium dalconate, calcium glycerate, calcium tartrate, calcium phytate, and enzyme agents such as dextranase, mutanase, and lysozyme can do.
  • the blending amount of these drugs is preferably in the range of 0.005 to 10% of the whole composition, particularly preferably in the range of 0.05 to 5%. If it is less than 0.005%, no effect is exhibited, and if it exceeds 10%, there may be a problem in taste and usability.
  • the composition for oral cavity of the present invention is in the form of toothpaste such as toothpaste, toothpaste, liquid toothpaste, mouthwash, mouth freshener, gargle tablet, denture cleaner, chewing gum and the like. It is possible, Each composition can be prepared by a conventional method using other components within the range not impairing the effects of the present invention, depending on the characteristics. In this case, in the case of dentifrice, abrasives, wetting agents, binders and the like are usually blended.
  • abrasive precipitated silica, silica gel, aluminosilicate, zeolite, dinoreconosilicate, dicalcium phosphate dihydrate and anhydride, calcium pyrophosphate, calcium carbonate, aluminum hydroxide, alumina, magnesium carbonate, (3) Magnesium phosphate, insoluble sodium metaphosphate, insoluble potassium metaphosphate, titanium oxide, hydrated hydroxyapatite, synthetic resin-based abrasives, etc. (blending amount: usually 5-50% of the total composition) .
  • wetting agent examples include polyhydric alcohols and the like among the above alcohols (mixing amount; usually 10 to 50% based on the entire composition).
  • binder examples include carrageenan, hydroxyethyl cellulose sodium, carboxymethylenosolerose sodium, hydroxyethylenosenolellose, hydroxypropinoresenellose, methylcellulose, hydroxypropylmethylcellulose, sodium alginate, alginic acid.
  • an anionic surfactant other than the above-mentioned surfactant, a cationic surfactant, a nonionic surfactant, and the like can be blended, for example, ⁇ -talifine sodium sulfin sulfonate, ⁇ Acylglutamate, 2-alkyl ⁇ -Carboxymethyl- ⁇ - Hydroxyethyl imidazolinium betaine, ⁇ Acyl taurate, Sucrose fatty acid ester ester, Alkyrol amide, Polyglycerol fatty acid ester, Polyoxyethylenepolyoxypropylene glycol, Polyoxyethylene sorbitan monostearate, lauroylole sarcosine sodium, alkylpolydarcoside, polyoxyethylene alkyl ether sulfosuccinate and the like may be added in an amount of 0 to 5% based on the entire composition.
  • a liquid oral composition such as a mouthwash
  • a thickener such as a styrene glycol
  • other surfactants such as sodium sulfate, sodium sulfate, sodium sulfate, sodium sulfate, sodium sulfate, sodium sulfate, sodium sulfate, sodium sulfate, sodium sulfate, sodium sulfate, sodium sulfate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium bicarbonate, sodium sulfate, sodium bicarbonate, sodium bicarbonate, sodium sulfate, sodium bicarbonate, sodium sulfate, sodium bicarbonate, sodium sulfate, sodium bicarbonate, sodium sulfate, sodium bicarbonate, sodium sulfate, sodium
  • the pH of the composition of the present invention is not particularly limited as long as it is within the range of safety in the oral cavity and human body, but is preferably pH 4 to 10, and more preferably pH 5. 5-9. If the pH is less than 4, there is a concern of decalcification depending on the application time, and if it exceeds pHIO, the usability and taste may deteriorate.
  • pH adjusters acetic acid, hydrochloric acid, sulfuric acid, nitric acid, citrate, phosphoric acid, sodium hydroxide, potassium hydroxide, sodium acetate, sodium carbonate, sodium citrate, sodium hydrogen citrate, sodium phosphate, phosphoric acid An appropriate amount of sodium hydride or the like can be blended.
  • the present invention will be specifically described with reference to examples and comparative examples, but the present invention is not limited to the following examples.
  • all% in each example is a mass percentage.
  • the number average molecular weight is the number average molecular weight calculated by the formula (1).
  • a model dentifrice was prepared according to the prescription in Table 1 below.
  • Silk BN-P made by NDC Co., Ltd. with a number average molecular weight of 500 was used as the hydrolyzed silk by the phosphoric acid hydrolysis method.
  • Silk peptide M-500 Cosmo Foods Co., Ltd., number average molecular weight 500
  • Promois registered trademark
  • Silk ⁇ (Seiwa Kasei Co., Ltd., number average molecular weight) as hydrolyzed silk other than phosphoric acid hydrolysis method 1, 000)
  • Synolec peptide 5 manufactured by Kanebo Co., Ltd., number average molecular weight 1,500
  • Synolec powder FD manufactured by Kanebo Co., Ltd., number average molecular weight 5,000
  • a 7% silk-five mouth-in aqueous solution was prepared by referring to Reference Example 1 ⁇ Production Method of Five-Mouth-in Aqueous Solution> of JP-A-2001-226242. What was prepared with reference to Example 1 of Japanese Patent No. 113072 was used. Furthermore, pork skin collagen is NMP collagen PS manufactured by Nippon Ham Co., Ltd., and cationized silk is 20% higher alkyl cationized silk peptide solution (Promois (registered trader) manufactured by Seiwa Kasei Co., Ltd.). Standard) S—CAQ) was used.
  • a phase was prepared by mixing and dissolving water-soluble components (sodium fluoride, sodium monofluorophosphate, hydrolyzed synolec, cation synolect, pork skin collagen, etc.) in purified water at room temperature.
  • sodium fluoride and sodium monofluorophosphate have a content approved in Japan of 1, OOOppm or less as fluorine ions, so in the examples sodium fluoride is 0.21% and sodium monofluorophosphate is 0. 73% was compounded mainly.
  • B phase was prepared by dispersing sodium polyacrylate (Rheozic 250H, manufactured by Nippon Pure Chemical Co., Ltd.) in purified water at room temperature.
  • the B phase was added and mixed in the A phase being stirred, and the sodium polyacrylate was swollen to prepare the C phase.
  • mix ingredients such as other ingredients (silk five mouth inscrubbing agent, polyoxyethylene (20 mol) hydrogenated castor oil), etc. in phase C using a 1.5 L kneader (manufactured by Ishiyama Machine Co., Ltd.) at room temperature.
  • the pressure was reduced to 4 kPa and defoamed to obtain 1.0 kg of a dentifrice.
  • the number average molecular weights of hydrolyzed silk, silk fiber mouth-in, and pig skin collagen were determined by measuring the total nitrogen amount, the first nitrogen determination method of the cosmetic raw material standard general test method, and the amino nitrogen amount by the formol titration method. Calculated by the equation (1).
  • a phase was prepared by mixing and dissolving water-soluble components (hydrolyzed silk, sodium fluoride, sodium monofluorophosphate, sodium saccharin, xylitol, 70% sorbite, etc.) in purified water at room temperature.
  • water-soluble components hydrolyzed silk, sodium fluoride, sodium monofluorophosphate, sodium saccharin, xylitol, 70% sorbite, etc.
  • silk BN-P manufactured by NDC Co., Ltd. having a number average molecular weight of 500 was used as the hydrolyzed silk by the phosphoric acid hydrolysis method.
  • Silk peptide M-500 (Cosmo Foods Co., Ltd., number average molecular weight 500), Promois (registered trademark) Synolec ⁇ (Seiwa Kasei Co., Ltd., number average molecular weight) as hydrolyzed silk other than the phosphate hydrolysis method 1, 000), Synolecpeptide 5 (manufactured by Kanebo Co., Ltd., number average molecular weight 1,500), and silk powder FD (manufactured by Kanebo Co., Ltd., number average molecular weight 5,000) were used.
  • sodium fluoride and sodium monofluorophosphate have a content approved in Japan of 1, OOOppm or less as fluorine ions.
  • sodium fluoride is 0.21% and sodium monofluorophosphate is 0.73%. It mix
  • triclosan isopropylmethylphenol, thymol, and polyacrylic acid in propylene glycol.
  • Phase B was prepared by dissolving and dispersing thorium (Rheology 250H, manufactured by Nippon Pure Chemicals Co., Ltd.), xanthan gum, sodium carboxymethylcellulose and the like at room temperature. Next, the B phase was added and mixed into the A phase being stirred, and the C phase was prepared by adding and mixing the examples in which polyoxyethylene hydrogenated castor oil was blended.
  • Phase C fragrance, anhydrous carboxylic acid, and other ingredients (dextranase, sodium lauryl sulfate, etc.) are mixed at room temperature using a 1.5 L kneader (manufactured by Ishiyama Kogyo Co., Ltd.), depressurized to 4 kPa and removed. Foaming was performed to obtain a dentifrice 1. Okg.
  • a specified amount of purified water was charged into a stainless steel container equipped with a three-one motor and a stirrer having rotating blades, and water-soluble components such as hydrolyzed silk among the blended components were charged and dissolved.
  • a specified amount of an organic solvent such as ethanol was added, and the oil-soluble component of the blended components was added and dissolved while stirring. .
  • the oil-soluble component was added to a container in which the water-soluble component was dissolved, and the mixture was stirred for 1 to 30 minutes to obtain a uniform solution to obtain a mouthwash.
  • Bovine ivory with reference to JM, Ten Cate et al. The influence of the organic matrix on de mineralization of bovine root dentin in vitro, Journal of Dental Research 73 (9): pl 523-1529, September, 1994) A collagen collagen degradation test was conducted.
  • the root dentin of the incisor extracted from a healthy ushi was cut out, and a dentin block measuring 5 mm in length, 5 mm in width, and 3 mm in height was produced.
  • one surface of the block is mirror-polished with # 4000 water-resistant abrasive paper, except for the 2mm X 2mm portion of the surface, a commercial nail burnish is applied to all surfaces, and the test is 2mm X 2mm in size. Surface (window) was made.
  • This test surface was decalcified with 0.1 M acetic acid (pH 5.0) for 2 days to obtain a demineralized layer having a depth of about 300 ⁇ m, that is, a collagen layer.
  • ⁇ ⁇ ⁇ 60% or more, less than 80%
  • 40% or more and less than 60%
  • one surface of the block is mirror-polished with # 4000 water-resistant abrasive paper, except for the 2mm X 2mm portion of the surface, and a commercial nail burnish is applied to all sides, and the size is 2mm X 2mm.
  • a test surface (window portion) was prepared. This sample was sterilized by irradiation with cobalt 60 gamma rays at a dose of 10.4 kj / kg.
  • the model dentifrice, dentifrice, and mouthwash prepared in Experiment 1 were used as they were. Examples:! To 19 and comparative examples:! To 6 model dentifrices and dentifrices were diluted three-fold with distilled water, and centrifuge (Hitachi 05PR_22, manufactured by Hitachi Eki Co., Ltd.) 3, The supernatant obtained by centrifugation at OOOrpm and room temperature for 10 minutes was further sterilized by filtration through a filter having a pore size of 0.22 zm (Millex-GS, manufactured by Nihon Millipore Co., Ltd.), and this was used as a treatment solution. In Examples 20 and 21, since the mouthwash was used, a solution obtained by sterilizing the stock solution by filtration was used.
  • the mutans bacteria that are caries-causing bacteria THB (Todd Hewitt Broth, Difco) medium containing (Stre ptococcus mutans ATCC25175) 1.
  • THB Todd Hewitt Broth, Difco
  • SHB Tin ptococcus mutans ATCC25175
  • the demineralization degree of each section was drawn from the TMR images of 15 aluminum step wedges taken together with the sections, and the mineral profile for each TMR image was drawn using an image analyzer (PIAS_V, manufactured by Pierce Co., Ltd.).
  • the amount of loss ⁇ ⁇ (decalcification amount) was calculated.
  • the delta dentin demineralization suppression rate of each Example and the comparative example was calculated by using the average ⁇ Z of the sample without treatment with the drug as the reference decalcification amount (the following formula (3)).
  • N 3 for each example and comparative example, and the average value was shown.
  • the evaluation criteria were as follows.
  • 50% or more and less than 70%
  • those containing hydrolyzed silk and fluorine compounds having a number average molecular weight of 500 to 5,000 showed excellent dentin collagen degradation inhibitory effect and demineralization inhibitory effect. .
  • those containing hydrolyzed synolec having a number average molecular weight of 500 to 1,000 and a fluorine compound showed a high inhibitory effect on dentin collagen degradation.
  • the hydrolyzed silk that has been hydrolyzed with phosphoric acid and the fluorine compound are particularly those containing hydrolyzed silk that has not been hydrolyzed with phosphoric acid and fluorine.
  • Dentin collagen higher than that containing the compound Degradation inhibitory effect was shown. This is presumably because hydrolyzed silk that had been hydrolyzed with phosphoric acid had a higher peptide content. On the other hand, when only hydrolyzed silk or only fluorine compounds are used as in the comparative examples, or when cationized silk or a silk fiber mouth-in or collagen having a considerably large number average molecular weight is contained, the dentin collagen degradation inhibitory effect or The decalcification inhibitory effect was not sufficient.
  • the dentin collagen degradation inhibitory effect and the demineralization inhibitory effect were excellent for those containing hydrolyzed silk having a number average molecular weight of 500 to 5,000 and a fluorine compound.
  • hydrolyzed silk having a number average molecular weight of 500 to 1,000, fluorine compound The one containing a high dentin collagen degradation inhibitory effect.
  • collagen degradation and decalcification of dentin can be remarkably suppressed by using hydrolyzed silk and a fluorine compound having a specific number average molecular weight. Furthermore, by adding a poorly water-soluble nonionic antibacterial agent and a surfactant and / or alcohol to solubilize it, both the collagen degradation inhibitory effect and the demineralization inhibitory effect of dentin are improved. Thus, it is possible to provide a composition for oral cavity in which the effect of preventing dentin caries has been dramatically improved.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Cosmetics (AREA)

Abstract

A composition for the oral cavity characterized by containing: a hydrolyzed silk having a number-average molecular weight, as calculated from total nitrogen amount and the amount of amino-form nitrogen, of 200-6,000; and a fluorine compound.

Description

明 細 書  Specification
加水分解シルクを含有する口腔用組成物  Oral composition containing hydrolyzed silk
技術分野  Technical field
[0001] 本発明は、歯牙の象牙質への高い吸着性能を持つ加水分解シルクで歯牙をコート することで、う蝕の原因となる菌ゃ酸、酵素などから歯牙を効果的に保護し、またフッ 素や抗菌剤の滞留性を向上させ、歯質の溶解 ·分解を顕著に防止することにより、象 牙質のう蝕予防効果を飛躍的に向上させた口腔用組成物に関するものである。 背景技術  [0001] The present invention coats teeth with hydrolyzed silk having a high ability to adsorb teeth to dentin, thereby effectively protecting the teeth from fungal acid, enzymes, etc. that cause caries. The present invention also relates to a composition for oral cavity in which the retention of fluorine and antibacterial agents is improved, and the dental caries preventive effect is dramatically improved by remarkably preventing dissolution and decomposition of the dentin. . Background art
[0002] 従来から、歯に対して有効成分を作用させる手段として、歯磨剤、洗口剤、ジエル、 錠剤、グミ、ガムなどといった手段がとられてきた。し力 ながら、歯磨剤や洗口剤の 場合には、吐き出した後では口腔内の有効成分の量が不十分であり、クリームゃジェ ルは使用性が悪ぐ固形インサートの場合には苦痛を伴ったりするといつた問題点が あった。また、いずれの場合にも、唾液による清浄作用によって有効成分の濃度低下 が起こり、効果が低下するという問題点があった。  Conventionally, as means for causing an active ingredient to act on teeth, means such as dentifrices, mouthwashes, jewels, tablets, gummi, gums and the like have been taken. However, in the case of dentifrices and mouthwashes, the amount of active ingredient in the oral cavity is insufficient after vomiting, and cream gel is painful for solid inserts with poor usability. When I was accompanied, there was a problem. In both cases, the concentration of the active ingredient is lowered due to the cleaning action by saliva, and the effect is lowered.
[0003] 一方、象牙質は、エナメル質よりも多孔質でかつ有機質に富んだ構造をとつており 、その有機質の大部分は I型コラーゲンである。象牙質う蝕の発症機序としては、以 下の通りである。まず、象牙質表面にプラークが付着し、プラーク中の細菌によって 糖の代謝がおこり、酸が産生される。その酸により象牙質のミネラル成分が溶出(脱 灰)し、コラーゲン質が露出する。更にコラーゲン質は、細菌や唾液に由来するコラゲ ナーゼにより分解され、ぅ窩(凹み)となる。象牙質う蝕は、これら脱灰とコラーゲン分 解の繰り返しにより、より深レ、う蝕へと進行する。これらのことから、象牙質う蝕の予防 効果を向上させるには、脱灰とコラーゲン分解の双方を効果的に抑制することが重 要である。  [0003] On the other hand, dentin has a structure that is more porous and rich in organic matter than enamel, and most of the organic matter is type I collagen. The onset mechanism of dentin caries is as follows. First, plaque adheres to the dentin surface, and sugars are metabolized by bacteria in the plaque to produce acid. The acid elutes (mineralizes) dentin minerals, exposing collagen. Furthermore, collagen is degraded by collagenase derived from bacteria and saliva to form an axilla (dent). Dentin caries progress to deeper depth and caries by repeated decalcification and collagen decomposition. For these reasons, it is important to effectively suppress both demineralization and collagen degradation in order to improve the effect of preventing dentin caries.
[0004] それに対し、歯質保護を謳う技術が提案されている。例えば、天然又は合成のカチ オン化ペプチド/タンパクとノニオン又は両性活性剤との組み合わせにより、組成物 の外観性向上を実現させた技術 (特開平 6— 9354号公報)は、フッ素の歯面取り込 み向上も目的としている力 カチオン化したペプチドやタンパクは、適用時間 1時間と レ、う長時間処置で効果を発揮している点で、効果は十分といえなレ、。コラーゲン又は ゼラチンを含有する洗口剤(特開 2003— 119157号公報)は、 目の硝子体や軟骨に 含まれる II型コラーゲンに対しては高い吸着能を示す一方、象牙質や骨、 口腔粘膜 に含まれる I型コラーゲンに対しては吸着能が小さいことから、歯牙への組成物の吸 着には大きな課題がある。脂肪酸塩を含有する歯面コート剤(特開 2000— 103726 号公報)は、脂肪酸塩そのものの界面活性作用により、薬剤処置後のうがいによって 有効成分が口腔内から流出してしまい、脂肪酸塩の歯面コート効果ならびに有効成 分の歯面滞留性には大きな課題が残る。また、茶ポリフヱノール、フッ素、アルミユウ ム塩からなる歯質耐酸性強化組成物(特開平 6— 298632号公報)は、味が悪い上 に、酸性領域で効果が発揮できるものであり、歯磨剤や洗口剤などの通常の使用下 である pHが中性付近においては、フッ素とアルミニウムイオンとの間に、更には歯磨 剤の場合、研磨剤との間にも不溶性沈殿が形成され、フッ素の歯質への取り込み向 上効果は、期待できない。 [0004] On the other hand, a technique for protecting tooth quality has been proposed. For example, a technology that improves the appearance of a composition by combining a natural or synthetic cationized peptide / protein with a nonionic or amphoteric active agent (JP-A-6-9354) incorporates a tooth surface of fluorine. The power of cationized peptides and proteins can be applied for 1 hour. I can't say that the effect is sufficient in that it is effective in long-term treatment. Mouthwash containing collagen or gelatin (JP-A-2003-119157) exhibits high adsorbability to type II collagen contained in the vitreous body and cartilage of the eye, while dentin, bone, and oral mucosa Adsorption of the composition to the teeth has a big problem because it has a small adsorption ability for type I collagen contained in the tooth. The tooth surface coating agent containing fatty acid salt (Japanese Patent Laid-Open No. 2000-103726) has a surface active action of the fatty acid salt itself, and the active ingredient flows out of the oral cavity due to gargle after the drug treatment. There are still significant issues regarding the surface coating effect and the retention of the effective tooth surface. In addition, tooth acid resistance enhancing composition (Japanese Patent Laid-Open No. 6-298632) composed of tea polyphenol, fluorine and aluminum salt has a bad taste and can be effective in the acidic region. Under normal use, such as a mouthwash, an insoluble precipitate is formed between fluorine and aluminum ions in the vicinity of neutral pH, and in the case of a dentifrice, and also with an abrasive. The effect of improving the incorporation into the tooth is not expected.
更には、シノレクを用いた技術として、絹蛋白質分解物を含有するストレス抑制剤(特 開 2003— 81868号公報)や、絹蛋白質加水分解物由来の生理活性作用組成物( 特開平 11 139986号公報)があるが、これらは、歯磨剤や洗口剤など口腔用の組 成物として処方設計されておらず、効果については不明である。また、シルクフイブ口 インからなるスクラブ剤(特開 2003— 113072号公報)があるが、これ自体を口腔内 に用いた場合、スクラブ効果こそ認められるものの、歯質の保護効果は認められない 。更には、シノレタフイブ口インからなる口腔用組成物(特開 2001— 226242号公報) も、特開 2003— 113072号公報と同様に加水分解したシルクでないため、フイブロイ ンの数平均分子量は、およそ 350, 000と大きぐ舌ゃ頰粘膜など粘膜への造膜保 護効果には優れるものの、硬い歯牙への吸着効果は低いため、歯面保護効果は劣 る。一般的に、天然由来のポリペプチド化合物は、分子量が小さいほど浸透性 '吸着 性が高い一方、造膜性が低ぐ分子量が大きいほど吸着性 ·浸透性が低くなる一方、 造膜性能が上がるといわれる。例えば、 (株)成和化成の製品カタログ(プロモイス(登 録商標))によると、コラーゲンポリペプチドの毛髪への吸着性及び浸透性は分子量 力 、さいほど高ぐ分子量が大きくなると造膜性は向上する一方、吸着性'浸透性は 低下するとある。 Furthermore, as a technique using Synolec, a stress inhibitor containing a silk protein degradation product (Japanese Patent Publication No. 2003-81868) and a bioactive composition derived from a silk protein hydrolyzate (Japanese Patent Laid-Open No. 11139986) However, these are not designed as oral compositions such as dentifrices and mouthwashes, and their effects are unclear. In addition, there is a scrubbing agent composed of silk fiber mouth (Japanese Patent Laid-Open No. 2003-113072), but when it is used in the oral cavity, a scrubbing effect is recognized, but a protective effect on the tooth quality is not recognized. Furthermore, the composition for oral cavity composed of sinoretafive mouth-in (Japanese Patent Laid-Open No. 2001-226242) is not hydrolyzed silk as in Japanese Patent Laid-Open No. 2003-113072, so the number average molecular weight of fibrin is about 350 Although it has excellent film-forming protection effects on mucous membranes such as 舌 000, which have a large tongue, the effect on the tooth surface is inferior because of its low adsorption effect on hard teeth. In general, naturally-occurring polypeptide compounds are more permeable and more adsorbable as the molecular weight is smaller, while the lower the film-forming property and the larger the molecular weight, the lower the adsorptivity and permeability, while the film-forming performance is improved. It is said. For example, according to Seiwa Kasei's product catalog (Promois (registered trademark)), the adsorptivity and penetrability of collagen polypeptides to hair are molecular weight, and the higher the molecular weight, the greater the film-forming property. While improving the adsorptive 'permeability There is a decline.
このように、いずれの公知技術も、短時間処理での歯牙の象牙質への吸着'保護 効果、フッ素、抗菌剤などの有効成分の歯面滞留性、製剤中での安定性、組成物の 香味などにぉレ、て大きな課題がある。  As described above, all known techniques are effective in adsorbing and protecting teeth on dentin in a short time, retention of tooth surfaces of active ingredients such as fluorine and antibacterial agents, stability in preparations, There is a big problem with the flavor.
[0006] これらの問題点を解決するために、短時間処理での歯牙の象牙質への効果的な吸 着能、フッ素、抗菌剤など有効成分の歯面滞留化機能、製剤中での安定性、香味な どを兼ね備えた組成物が望まれる。  [0006] In order to solve these problems, effective adsorption ability of teeth to dentin in a short time treatment, retention function of tooth surfaces of active ingredients such as fluorine and antibacterial agents, stability in preparations A composition having both sexiness and flavor is desired.
発明の開示  Disclosure of the invention
発明が解決しょうとする課題  Problems to be solved by the invention
[0007] 本発明は、上記問題点を解決し、短時間処理での象牙質う蝕予防効果の高い口 腔用組成物を提供することを目的とする。 [0007] An object of the present invention is to solve the above-mentioned problems and to provide a composition for oral cavity having a high effect of preventing dentine caries in a short time treatment.
課題を解決するための手段  Means for solving the problem
[0008] 本発明者らは、上記目的を達成するため鋭意検討を重ねた結果、絹糸を精製して 得られるシノレタフイブ口インを更に酸 'アルカリ、酵素などで加水分解したペプチドィ匕 合物とフッ素化合物との組合せにより、 I型コラーゲンを主体とする有機質を含有する 象牙質に対し、優れたコラーゲン分解抑制能 ·脱灰抑制能を見出した。更には難水 溶性非イオン性抗菌剤をカ卩えることで、コラーゲン分解抑制能'脱灰抑制能がより向 上することを見出し、本発明を完成するに至った。 [0008] As a result of intensive studies to achieve the above object, the inventors of the present invention have developed a peptide complex obtained by further hydrolyzing a sinoretive mouth-in obtained by refining silk yarn with an acid, an alkali, an enzyme, and the like. In combination with compounds, we have found excellent collagen degradation-inhibiting and demineralization-inhibiting properties for dentin containing organic substances mainly composed of type I collagen. Furthermore, it has been found that the ability to inhibit collagen degradation and the ability to suppress decalcification are further improved by providing a poorly water-soluble nonionic antibacterial agent, and the present invention has been completed.
従って、本発明は、  Therefore, the present invention
[I]総窒素量とアミノ態窒素量をもとに計算される数平均分子量が 200〜6, 000の 加水分解シルクと、フッ素化合物とを含有することを特徴とする口腔用組成物、 [I] An oral composition comprising hydrolyzed silk having a number average molecular weight of 200 to 6,000 calculated based on the total nitrogen content and amino nitrogen content, and a fluorine compound,
[II]加水分解シノレクがリン酸加水分解により得られたものである [I]記載の口腔用組 成物、 [II] Hydrolyzed synolec is obtained by phosphoric acid hydrolysis, The composition for oral cavity according to [I],
[III]加水分解シルクの配合量が組成物全体の 0.:!〜 10質量%であり、フッ素化合 物の配合量が組成物全体の 0. 02〜3質量%である [I]又は [II]記載の口腔用組成 物、  [III] The amount of hydrolyzed silk is 0.:! To 10% by mass of the entire composition, and the amount of fluorinated compound is 0.02 to 3% by mass of the entire composition [I] or [ II] oral cavity composition,
[IV]更に、難水溶性非イオン性抗菌剤と、界面活性剤及び Z又はアルコール類を 含有することを特徴とする [I]〜 [III]のレ、ずれかに記載の口腔用組成物、 [V]難水溶性非イオン性抗菌剤がトリクロサン又はイソピロピルメチルフエノールであ り、界面活性剤が平均付加モル数が 5〜: 100のポリオキシエチレン硬化ヒマシ油又は アルキル硫酸エステル塩であり、アルコールがプロピレングリコール、ポリエチレングリ コーノレ(# 200〜6000)、エチレングリコーノレ、グリセリン、ソルビトール又はエタノー ルである [IV]記載の口腔用組成物、 [IV] The oral composition according to any one of [I] to [III], further comprising a slightly water-soluble nonionic antibacterial agent, a surfactant and Z or an alcohol. , [V] The poorly water-soluble nonionic antibacterial agent is triclosan or isopropylmethylphenol, and the surfactant is polyoxyethylene hydrogenated castor oil or alkyl sulfate ester salt having an average added mole number of 5 to 100. The composition for oral cavity according to [IV], wherein the alcohol is propylene glycol, polyethylene glycolate (# 200 to 6000), ethylene glycolanol, glycerin, sorbitol or ethanol,
[VI]難水溶性非イオン性抗菌剤の配合量が組成物全体の 0. 0:!〜 2質量%であり、 界面活性剤の配合量が組成物全体の 0. :!〜 5質量%であり、アルコールの配合量 が組成物全体の 0.:!〜 50質量%である [IV]又は [V]記載の口腔用組成物を提供 する。  [VI] The amount of the poorly water-soluble nonionic antibacterial agent is 0.0 :! to 2% by mass of the whole composition, and the amount of the surfactant is 0.0.% To 5% by mass of the whole composition The composition for oral cavity according to [IV] or [V] is provided, wherein the blending amount of alcohol is 0.:! To 50% by mass of the entire composition.
発明の効果  The invention's effect
[0009] 本発明によれば、特定の数平均分子量の加水分解シルクとフッ素化合物を用いる ことにより、象牙質のコラーゲン分解と脱灰を顕著に抑制することができる。更には難 水溶性非イオン性抗菌剤とそれを可溶化させるための界面活性剤及び/又はアル コール類を加えることで、象牙質のコラーゲン分解抑制効果と脱灰抑制効果の双方 を向上させることにより、象牙質う蝕の予防効果が飛躍的に向上した口腔用組成物を 提供すること力 Sできる。  [0009] According to the present invention, by using hydrolyzed silk having a specific number average molecular weight and a fluorine compound, collagen degradation and decalcification of dentin can be remarkably suppressed. Furthermore, by adding a hardly water-soluble nonionic antibacterial agent and a surfactant and / or alcohol to solubilize it, both the collagen degradation inhibitory effect and the demineralization inhibitory effect of dentin are improved. Thus, it is possible to provide a composition for oral cavity in which the effect of preventing dentin caries has been dramatically improved.
発明を実施するための最良の形態  BEST MODE FOR CARRYING OUT THE INVENTION
[0010] 本発明の口腔用組成物は、加水分解シノレクを含有することを特徴とする。 [0010] The composition for oral cavity of the present invention is characterized by containing hydrolyzed synolec.
ここで、加水分解シルクは、蚕の吐糸する繭糸を精製して得られるシルクフイブロイ ンを酸 ·アルカリ、酵素などで加水分解することで得ることができる。繭糸には、中心 部にフイブ口イン、周囲にセリシンが存在し、存在比は一般的にフイブ口イン:セリシン Here, the hydrolyzed silk can be obtained by hydrolyzing silk fibroin obtained by refining the silk thread spun from the silkworm with an acid, alkali, enzyme or the like. A silk thread has a five mouth-in in the center and sericin in the periphery.
= 70〜80%: 20〜30% (質量百分率)であることが知られている。 = 70-80%: It is known that it is 20-30% (mass percentage).
絹糸は、まず養蚕農家で生産された繭を乾繭、煮繭後繰糸して生糸を作製し、次 いで生糸の精練を行って絹糸又は絹織物とする。精鍊方法としては、アルカリ性ナト リウム塩ゃ石鹼を含む水溶液中で煮沸する方法(アルカリ石鹼精鍊)が最も一般的で あり、この精鍊によって、絹糸の外側のセリシンは除去され、中心部のフイブ口インだ けに精製される。加水分解シルクは、このフイブ口イン(平均分子量:約 350, 000)を 酸'アルカリ、酵素などで加水分解することで得られるが、加水分解する程度により、 様々な分子量のものに調製できる。また、本発明の場合、特にリン酸加水分解により 得られた加水分解シルクが好ましレ、。 As for silk thread, first, silkworms produced by a sericulture farmer are dried and boiled to produce raw silk, and then raw silk is scoured to obtain silk thread or silk fabric. The most common method of boiling is a method of boiling in an aqueous solution containing alkaline sodium salt gypsum (alkaline stone koji), which removes sericin on the outside of the silk thread, Purified by mouth-in only. Hydrolyzed silk can be obtained by hydrolyzing this hive mouth-in (average molecular weight: about 350,000) with acid 'alkali, enzyme, etc., but depending on the degree of hydrolysis, Various molecular weights can be prepared. In the case of the present invention, hydrolyzed silk obtained by phosphoric acid hydrolysis is particularly preferred.
本発明で用いる加水分解シルクは、数平均分子量が 200〜6, 000のものであるが 、好ましく fま 500〜5, 000、更に好ましく ίま 500〜1, 000のものカょレヽ。数平均分子 量が 200より小さい場合には、歯牙への吸着性はあるものの、造膜性が極端に低ぐ 6, 000を超えると造膜性は高レ、ものの、吸着性が低下するため、効果は低下する。 加水分解シノレクは、様々な数平均分子量のグレードが各社から市販されており、そ れらを必要に応じ使い分けすることができる。市販品としては、リン酸加水分解による 加水分解シノレクとして、シルク ΒΝ— Ρ ( (株) NDC製、数平均分子量 500)が挙げら れ、酵素加水分解による加水分解シルクとして、シルクペプチド Μ_ 500 (コスモ食 品(株)製、数平均分子量 500)、その他の製法による加水分解シルクとして、プロモ イス (登録商標)シノレク ΙΟΟΟρ ( (株)成和化成製、数平均分子量 1 , 000)、シノレクぺ プチド 5 (カネボウ(株)製、数平均分子量 1 , 500)、シルクパウダー FD (カネボウ (株 )製、数平均分子量 5, 000)などが挙げられる。本発明の加水分解シルクは、非力チ オン性乃至ノニオン性である。  The hydrolyzed silk used in the present invention has a number average molecular weight of 200 to 6,000, preferably a f of 500 to 5,000, more preferably a clay of 500 to 1,000. If the number average molecular weight is less than 200, there is adsorptivity to teeth, but the film-forming property is extremely low, and if it exceeds 6,000, the film-forming property is high, but the adsorptivity decreases. The effect is reduced. Hydrolyzed synolec is available from various companies in grades with various number average molecular weights, and they can be used as needed. Commercially available products include silk レ ク -Ρ (manufactured by NDC Co., Ltd., number average molecular weight 500) as hydrolysis synolec by phosphoric acid hydrolysis, and silk peptide Μ_500 ( Cosmo Foods Co., Ltd., number average molecular weight 500), and other hydrolyzed silks produced by Promose (registered trademark) Synolec ΙΟΟΟρ (manufactured by Seiwa Kasei Co., Ltd., number average molecular weight 1,000), Synolecpe Examples include Peptide 5 (manufactured by Kanebo Co., Ltd., number average molecular weight 1,500), Silk Powder FD (manufactured by Kanebo Co., Ltd., number average molecular weight 5,000), and the like. The hydrolyzed silk of the present invention is ineffective thionic or nonionic.
[0011] 数平均分子量は、一般的にゲルろ過クロマトグラフィー(GPC)、分析窒素値の計 算によって算出する方法がある力 本発明に用レ、る加水分解シルクのようにポリぺプ チドィ匕合物に対しては、後者を用いることが多い。更に詳述すると、本発明の加水分 解シルクの数平均分子量は、分子中の総窒素量、アミノ態窒素量、構成アミノ酸の平 均分子量をもとに下記式(1)によって算出される。 [0011] The number average molecular weight can generally be calculated by gel filtration chromatography (GPC) and calculation of analytical nitrogen value. For this invention, a polypeptide such as hydrolyzed silk can be used. The latter is often used for compounds. More specifically, the number average molecular weight of the hydrolyzed silk of the present invention is calculated by the following formula (1) based on the total nitrogen amount in the molecule, the amino nitrogen amount, and the average molecular weight of the constituent amino acids.
[数 1]  [Number 1]
(構成アミノ酸の平均分子量 1 8 ) X総窒素量  (Average molecular weight of constituent amino acids 1 8) X total nitrogen content
数平均分子量 = 十 1 8 ( 1 ) Number average molecular weight = 10 18 (1)
ァミノ態窒素量  Amino nitrogen content
[0012] 上記式(1)において、構成アミノ酸の平均分子量は、通常のアミノ酸分析により求 めた構成アミノ酸の存在比率(%)に各アミノ酸の分子量を掛け合わせたものを示し、 総窒素量は、化粧品原料基準一般試験法の窒素定量法第一法あるいはガスクロマ トグラフィー(GC)、ァミノ態窒素量は、ホルモール滴定法によって測定できる。  In the above formula (1), the average molecular weight of the constituent amino acids is obtained by multiplying the abundance ratio (%) of constituent amino acids obtained by ordinary amino acid analysis by the molecular weight of each amino acid, and the total nitrogen amount is In addition, the first nitrogen determination method of the cosmetic raw material standard general test method or gas chromatography (GC), the amount of amino nitrogen can be measured by a formol titration method.
[0013] 上記加水分解シノレクの配合量は、特に制限されるものではなレ、が、組成物全体の 0. 1〜: 10% (質量百分率、以下同じ)が好適であり、特に 0. 5〜5%が望ましい。 0. 1 %より低い場合には、本発明の効果が十分には得られず、 10%を超えると、味や 使用感が悪くなる場合がある。 [0013] The amount of the hydrolyzed synolec is not particularly limited. 0.1 to 10% (percentage by mass, the same shall apply hereinafter) is preferable, and 0.5 to 5% is particularly desirable. When the content is lower than 0.1%, the effect of the present invention cannot be sufficiently obtained. When the content exceeds 10%, the taste and feeling of use may be deteriorated.
[0014] 本発明の口腔用組成物にはフッ素化合物を配合する。本発明に用いるフッ素化合 物としては、フッ化ナトリウム、モノフルォロリン酸ナトリウム、フッ化第一スズ等が挙げ られ、特にフッ化ナトリウム、モノフルォロリン酸ナトリウムが好ましい。う蝕予防の観点 から、これらのフッ素化合物を組成物全体の 0. 02〜3%配合することが好ましぐ特 にフツイ匕ナトリウムの場合は組成物全体の 0. 02〜1%、より好ましくは 0. 02〜0. 7 %であり、モノフルォロリン酸ナトリウムの場合は、組成物全体の 0. 05〜3%、より好 ましくは 0. 07〜2. 5%であることが好ましい。  [0014] The oral composition of the present invention contains a fluorine compound. Examples of the fluorinated compound used in the present invention include sodium fluoride, sodium monofluorophosphate, stannous fluoride and the like, and sodium fluoride and sodium monofluorophosphate are particularly preferred. From the viewpoint of caries prevention, it is preferable to add these fluorine compounds in an amount of 0.02 to 3% of the whole composition, particularly in the case of Futsui sodium, more preferably 0.0 to 1% of the whole composition. Is 0.02 to 0.7%, and in the case of sodium monofluorophosphate, it is preferably 0.05 to 3%, more preferably 0.07 to 2.5% of the total composition.
[0015] また、本発明は、更に難水溶性非イオン性抗菌剤を配合することが好ましい。難水 溶性非イオン性抗菌剤としては、トリクロサン (水への溶解度; 0. 001g/l00mL (20 °C)、環境省ホームページ記載値)、イソプロピルメチルフエノール(同; 0· 015g/10 0mL (25°C)、大阪化成(株)カタログ記載値)、チモール(同; 0· 098g/100mL (2 5°C)、大阪化成 (株)カタログ記載値)など、 20〜25°Cでの水への溶解度が 0· lg/ lOOmL以下の非イオン性抗菌剤が挙げられ、中でもトリクロサン、イソプロピルメチル フエノールが好ましい。本発明においては、上記難水溶性非イオン性抗菌剤の 1種 あるいは 2種以上を組み合わせて使用することができる。配合量は、組成物全体の 0 . 001〜2%力 S好ましく、より好ましくは 0. 01〜: 1%である。 0. 001 %未満では十分 な殺菌効果が発揮されない場合があり、また、 2%を超えると製剤中への可溶化が困 難となったり、味や使用性が悪くなる場合がある。  [0015] In the present invention, it is preferable to further blend a poorly water-soluble nonionic antibacterial agent. Difficult water-soluble nonionic antibacterial agents include triclosan (water solubility; 0.001 g / l00 mL (20 ° C), the value listed on the Ministry of the Environment website), isopropylmethylphenol (same; 0 · 015 g / 10 0 mL (25 ° C), Osaka Kasei Co., Ltd. catalog value), thymol (same; 0 · 098g / 100mL (25 ° C), Osaka Kasei Co., Ltd. catalog value), etc., to water at 20-25 ° C Examples include nonionic antibacterial agents having a solubility of 0 · lg / lOOmL or less, among which triclosan and isopropylmethylphenol are preferable. In the present invention, one or two or more of the poorly water-soluble nonionic antibacterial agents can be used in combination. The blending amount is preferably 0.001 to 2% force S of the whole composition, more preferably 0.01 to 1%. If it is less than 001%, the sufficient bactericidal effect may not be exhibited, and if it exceeds 2%, solubilization in the preparation may be difficult, and the taste and usability may be deteriorated.
[0016] 更に、本発明の口腔用組成物には、難水溶性非イオン性抗菌剤及び油溶性香料 の溶解性を向上させるために、界面活性剤を配合することができる。界面活性剤とし ては、ポリオキシエチレン硬化ヒマシ油やアルキル硫酸エステル塩が好ましレ、。ポリオ キシエチレン硬化ヒマシ油は酸化エチレンの平均付加モル数が 5〜100のものであり 、特に歯磨剤に対しては 5〜20、洗口剤に対しては 40〜: 100のものが好ましレ、。平 均付加モル数が 5未満では油溶性が高まり、起泡力の低下を招き、 100を超えると難 水溶性非イオン性抗菌剤の安定性が低下する場合がある。ポリオキシエチレン硬化 ヒマシ油の配合量は、組成物に対し 0. 1〜5%、特に歯磨剤の場合には 0. 5〜2. 5 %、洗口剤の場合には 0. 2〜2%が好適である。 0. 1%未満では難水溶性非イオン 性抗菌剤の安定化効果が十分得られず、 5%を超えると十分な起泡力が得られない 場合がある。 [0016] Furthermore, a surfactant can be added to the oral composition of the present invention in order to improve the solubility of the poorly water-soluble nonionic antibacterial agent and oil-soluble fragrance. As surfactants, polyoxyethylene hydrogenated castor oil and alkyl sulfate esters are preferred. Polyoxyethylene hydrogenated castor oil has an average added mole number of ethylene oxide of 5 to 100. Especially, 5 to 20 for dentifrice and 40 to 100 for mouthwash are preferred. ,. If the average number of added moles is less than 5, oil solubility increases and foaming power decreases, and if it exceeds 100, stability of the poorly water-soluble nonionic antibacterial agent may decrease. Polyoxyethylene curing The amount of castor oil blended is preferably 0.1-5% of the composition, especially 0.5-2.5% for dentifrice and 0.2-2% for mouthwash. is there. If it is less than 1%, the stabilizing effect of the poorly water-soluble nonionic antibacterial agent cannot be obtained sufficiently, and if it exceeds 5%, sufficient foaming power may not be obtained.
[0017] アルキル硫酸エステル塩としては、例えばォクチル硫酸、デシル硫酸、ラウリル硫酸 、ミリスチル硫酸、パルミチル硫酸、ステアリル硫酸などのナトリウム、カリウム、リチウム などのアルカリ金属塩が挙げられ、中でも起泡力に優れるラウリル硫酸ナトリウムが最 も好ましい。アルキル硫酸エステル塩の配合量としては、好ましくは 0. 05〜5%であ り、より好ましくは歯磨剤の場合には 0.:!〜 2. 5。/0であり、洗口剤の場合には 0.:!〜 0. 5%が好適である。 0. 05%未満では十分な起泡性が得られず、 5%を超えると発 泡性が強ぐ使用感が低下するおそれがある。 [0017] Examples of the alkyl sulfate ester salts include alkali metal salts such as sodium, potassium, lithium and the like such as octyl sulfate, decyl sulfate, lauryl sulfate, myristyl sulfate, palmityl sulfate, stearyl sulfate, etc. Sodium lauryl sulfate is most preferred. The blending amount of the alkyl sulfate ester salt is preferably 0.05 to 5%, and more preferably 0.5 to 2.5 for a dentifrice. / 0, in the case of mouthwashes is preferably 0.:!~ 0.5%. If it is less than 0.05%, sufficient foaming property cannot be obtained, and if it exceeds 5%, foaming property is strong and the feeling of use may be lowered.
[0018] また、界面活性剤に代えて、又は界面活性剤と共にアルコール類を配合することが できる。アルコール類としては、プロピレングリコール、ポリエチレングリコール(# 200 〜6000)、エチレングリコール、グリセリン、ソノレビトーノレ、エタノール等の 1種又は 2 種以上が使用でき、配合量は組成物全体の 0.:!〜 50%が好ましぐより好ましくは 1 〜40%である。 0. 1 %より少ない場合、難水溶性非イオン性抗菌剤を安定に配合で きない場合があり、 50%を超えると味や使用性を悪化させる場合がある。  [0018] Alternatively, alcohols can be blended in place of the surfactant or together with the surfactant. As the alcohol, one or more of propylene glycol, polyethylene glycol (# 200 to 6000), ethylene glycol, glycerin, sonorebitol, ethanol and the like can be used, and the blending amount is 0.:! To 50 of the entire composition. % Is more preferably 1 to 40%. When the content is less than 0.1%, a poorly water-soluble nonionic antibacterial agent may not be stably blended, and when it exceeds 50%, the taste and usability may be deteriorated.
[0019] 更に、他のう蝕予防成分として、効果を持つ既知の薬剤が使用でき、塩化カルシゥ ム、硝酸カルシウム、硫酸カルシウム、グリセ口リン酸カルシウム、水酸化カルシウムな どの無機性カルシウム化合物や、乳酸カルシウム、酢酸カルシウム、マロン酸カルシ ゥム、クェン酸カルシウム、ダルコン酸カルシウム、グリセリン酸カルシウム、酒石酸力 ノレシゥム、フィチン酸カルシウムなどの有機性カルシウム化合物、デキストラナーゼ、 ムタナーゼ、リゾチームなどの酵素剤を組み合わせて使用することができる。これらの 薬剤の配合量は、組成物全体の好ましくは 0. 005〜: 10%の範囲であり、特に好まし くは 0. 05〜5%の範囲である。 0. 005%より少ない場合には効果が発現されず、ま た 10%を超える場合には、味や使用性に問題が起こる場合がある。  [0019] Furthermore, as other caries-preventing ingredients, known effective drugs can be used. Inorganic calcium compounds such as calcium chloride, calcium nitrate, calcium sulfate, calcium glycephosphate, calcium hydroxide, and calcium lactate Used in combination with organic calcium compounds such as calcium acetate, calcium malonate, calcium citrate, calcium dalconate, calcium glycerate, calcium tartrate, calcium phytate, and enzyme agents such as dextranase, mutanase, and lysozyme can do. The blending amount of these drugs is preferably in the range of 0.005 to 10% of the whole composition, particularly preferably in the range of 0.05 to 5%. If it is less than 0.005%, no effect is exhibited, and if it exceeds 10%, there may be a problem in taste and usability.
[0020] 本発明の口腔用組成物は、練歯磨、潤製歯磨、液体歯磨等の歯磨剤、洗口剤、 口 中清涼剤、うがい用錠剤、義歯用洗浄剤、チューインガム等の形態とすることができ、 それぞれの組成物は、その特徴に応じ、その他の成分を本発明の効果を損ねない 範囲で使用し、通常の方法で調製することができる。この場合、歯磨剤の場合、通常 研磨剤、湿潤剤、粘結剤等が配合される。 [0020] The composition for oral cavity of the present invention is in the form of toothpaste such as toothpaste, toothpaste, liquid toothpaste, mouthwash, mouth freshener, gargle tablet, denture cleaner, chewing gum and the like. It is possible, Each composition can be prepared by a conventional method using other components within the range not impairing the effects of the present invention, depending on the characteristics. In this case, in the case of dentifrice, abrasives, wetting agents, binders and the like are usually blended.
[0021] 研磨剤としては、沈降性シリカ、シリカゲル、アルミノシリケート、ゼォライト、ジノレコノ シリケート、第 2リン酸カルシウム · 2水和物及び無水物、ピロリン酸カルシウム、炭酸 カルシウム、水酸化アルミニウム、アルミナ、炭酸マグネシウム、第 3リン酸マグネシゥ ム、不溶性メタリン酸ナトリウム、不溶性メタリン酸カリウム、酸化チタン、ハイド口キシァ パタイト、合成樹脂系研磨剤等が挙げられる(配合量;通常、組成物全体に対して 5 〜50%)。 [0021] As the abrasive, precipitated silica, silica gel, aluminosilicate, zeolite, dinoreconosilicate, dicalcium phosphate dihydrate and anhydride, calcium pyrophosphate, calcium carbonate, aluminum hydroxide, alumina, magnesium carbonate, (3) Magnesium phosphate, insoluble sodium metaphosphate, insoluble potassium metaphosphate, titanium oxide, hydrated hydroxyapatite, synthetic resin-based abrasives, etc. (blending amount: usually 5-50% of the total composition) .
[0022] 湿潤剤としては、上記アルコール類のうち、多価アルコール等が挙げられる(配合 量;通常、組成物全体に対して 10〜50%)。  [0022] Examples of the wetting agent include polyhydric alcohols and the like among the above alcohols (mixing amount; usually 10 to 50% based on the entire composition).
[0023] 粘結剤としては、カラギーナン、ヒドロキシェチルセルロースナトリウム、カルボキシメ チノレセノレロースナトリウム、ヒドロキシェチノレセノレロース、ヒドロキシプロピノレセノレロース 、メチルセルロース、ヒドロキシプロピルメチルセルロース、アルギン酸ナトリウム、アル ギン酸プロピレングリコールエステル、ポリアクリル酸、ポリアクリル酸ナトリウム、キサ ンタンガム、タラガム、グァガム、ローカストビーンガム、ジエランガム、ゼラチン、カー ドラン、アラビアガム、寒天、ぺクチン、ポリビエルアルコール、ポリビニルピロリドン、 プノレラン等が挙げられる(配合量;通常、組成物全体に対して 0. 1〜5%)。  [0023] Examples of the binder include carrageenan, hydroxyethyl cellulose sodium, carboxymethylenosolerose sodium, hydroxyethylenosenolellose, hydroxypropinoresenellose, methylcellulose, hydroxypropylmethylcellulose, sodium alginate, alginic acid. Propylene glycol ester, polyacrylic acid, sodium polyacrylate, xanthan gum, tara gum, guar gum, locust bean gum, gelatin gum, gelatin, cardan, gum arabic, agar, pectin, polyvinyl alcohol, polyvinyl pyrrolidone, punoreran, etc. (Blending amount; usually 0.1 to 5% based on the entire composition).
[0024] また、必要に応じ、上記した界面活性剤以外のァニオン性界面活性剤、カチオン 性界面活性剤、非イオン性界面活性剤等を配合し得、例えば、 α—才レフインスルホ ン酸ナトリウム、 Ν ァシルグルタメート、 2—アルキル Ν—カルボキシメチルー Ν— ヒドロキシェチルイミダゾリニゥムベタイン、 Ν ァシルタウレート、ショ糖脂肪酸エステ ノレ、アルキロールアマイド、ポリグリセリン脂肪酸エステル、ポリオキシエチレンポリオ キシプロピレングリコール、ポリオキシエチレンソルビタンモノステアレート、ラウロイノレ サルコシンナトリウム、アルキルポリダルコシド、ポリオキシエチレンアルキルエーテル スルホこはく酸塩等を組成物全体に対して 0〜5%配合し得る。  [0024] Further, if necessary, an anionic surfactant other than the above-mentioned surfactant, a cationic surfactant, a nonionic surfactant, and the like can be blended, for example, α-talifine sodium sulfin sulfonate,ァ Acylglutamate, 2-alkyl Ν-Carboxymethyl- Ν- Hydroxyethyl imidazolinium betaine, Ν Acyl taurate, Sucrose fatty acid ester ester, Alkyrol amide, Polyglycerol fatty acid ester, Polyoxyethylenepolyoxypropylene glycol, Polyoxyethylene sorbitan monostearate, lauroylole sarcosine sodium, alkylpolydarcoside, polyoxyethylene alkyl ether sulfosuccinate and the like may be added in an amount of 0 to 5% based on the entire composition.
[0025] また、洗口剤等の液体口腔用組成物の場合、上記粘稠剤や他の界面活性剤を配 合すること力 Sできる。 [0026] 更に、本発明の口腔用組成物には必要に応じ、サッカリン、キシリトール等の甘味 剤、その他防腐剤、香料、着色剤、 pH調整剤、賦形剤、各種薬効成分等を配合する こと力 Sできる。 [0025] In the case of a liquid oral composition such as a mouthwash, it is possible to combine the above thickener and other surfactants. [0026] Furthermore, the oral composition of the present invention is blended with sweeteners such as saccharin and xylitol, as well as other preservatives, fragrances, colorants, pH adjusters, excipients, various medicinal ingredients, and the like as necessary. That power S.
[0027] 本発明組成物の pHは、 口腔内及び人体に安全性上問題ない範囲であれば、特に 限定されるものではなレ、が、望ましくは pH4〜10であり、更に望ましくは pH5. 5〜9 である。 pH4未満の場合には適用時間によっては脱灰の懸念があり、 pHIO超の場 合には、使用性や味が悪くなる場合がある。 pH調整剤として、酢酸、塩酸、硫酸、硝 酸、クェン酸、リン酸、水酸化ナトリウム、水酸化カリウム、酢酸ナトリウム、炭酸ナトリウ ム、クェン酸ナトリウム、クェン酸水素ナトリウム、リン酸ナトリウム、リン酸水素ナトリウム 等を適量配合し得る。  [0027] The pH of the composition of the present invention is not particularly limited as long as it is within the range of safety in the oral cavity and human body, but is preferably pH 4 to 10, and more preferably pH 5. 5-9. If the pH is less than 4, there is a concern of decalcification depending on the application time, and if it exceeds pHIO, the usability and taste may deteriorate. As pH adjusters, acetic acid, hydrochloric acid, sulfuric acid, nitric acid, citrate, phosphoric acid, sodium hydroxide, potassium hydroxide, sodium acetate, sodium carbonate, sodium citrate, sodium hydrogen citrate, sodium phosphate, phosphoric acid An appropriate amount of sodium hydride or the like can be blended.
実施例  Example
[0028] 以下、実施例及び比較例を示し、本発明を具体的に説明するが、本発明は下記実 施例に制限されるものではない。なお、各例中の%はいずれも質量百分率である。ま た、下記例で、数平均分子量は前記式(1)で計算される数平均分子量である。  Hereinafter, the present invention will be specifically described with reference to examples and comparative examples, but the present invention is not limited to the following examples. In addition, all% in each example is a mass percentage. In the following examples, the number average molecular weight is the number average molecular weight calculated by the formula (1).
[0029] 実験 1 :初期脱灰象牙晳のコラーゲン分解抑制実験  [0029] Experiment 1: Inhibition of collagen degradation in early demineralized ivory
[実施例:!〜 21、比較例:!〜 6]  [Example:! To 21, Comparative example:! To 6]
( 1 )モデル歯磨剤の調製 (実施例:!〜 7)  (1) Preparation of model dentifrice (Example:! ~ 7)
下記表 1の処方に従い、モデル歯磨剤を調製した。リン酸加水分解法による加水分 解シルクとしては、数平均分子量 500の(株) NDC製のシルク BN— Pを用いた。リン 酸加水分解法以外の加水分解シルクとして、シルクペプチド M— 500 (コスモ食品( 株)製、数平均分子量 500)、プロモイス(登録商標)シルク ΙΟΟΟρ ( (株)成和化成製 、数平均分子量 1 , 000)、シノレクペプチド 5 (カネボウ (株)製、数平均分子量 1 , 500 )、シノレクパウダー FD (カネボウ(株)製、数平均分子量 5, 000)を用いた。また、 7% シルクフイブ口イン水溶液は、特開 2001— 226242号公報の参考例 1〈フイブ口イン 水溶液の製法〉を参考にして調製したもの、同様にシルクフイブ口インスクラブ剤は、 特開 2003— 113072号公報の実施例 1を参考にして調製したものを使用した。更に 、豚皮コラーゲンは、 日本ハム(株)製 NMPコラーゲン PS、カチオン化シルクは、(株 )成和化成製 20%高級アルキルカチオン化シルクペプチド溶液(プロモイス(登録商 標) S— CAQ)を用いた。 A model dentifrice was prepared according to the prescription in Table 1 below. Silk BN-P made by NDC Co., Ltd. with a number average molecular weight of 500 was used as the hydrolyzed silk by the phosphoric acid hydrolysis method. Silk peptide M-500 (Cosmo Foods Co., Ltd., number average molecular weight 500), Promois (registered trademark) Silk ΙΟΟΟρ (Seiwa Kasei Co., Ltd., number average molecular weight) as hydrolyzed silk other than phosphoric acid hydrolysis method 1, 000), Synolec peptide 5 (manufactured by Kanebo Co., Ltd., number average molecular weight 1,500), Synolec powder FD (manufactured by Kanebo Co., Ltd., number average molecular weight 5,000) were used. Further, a 7% silk-five mouth-in aqueous solution was prepared by referring to Reference Example 1 <Production Method of Five-Mouth-in Aqueous Solution> of JP-A-2001-226242. What was prepared with reference to Example 1 of Japanese Patent No. 113072 was used. Furthermore, pork skin collagen is NMP collagen PS manufactured by Nippon Ham Co., Ltd., and cationized silk is 20% higher alkyl cationized silk peptide solution (Promois (registered trader) manufactured by Seiwa Kasei Co., Ltd.). Standard) S—CAQ) was used.
歯磨剤の調製方法としては、精製水中に水溶成分 (フッ化ナトリウム、モノフルォロリ ン酸ナトリウム、加水分解シノレク、カチオンィ匕シノレク、豚皮コラーゲン等)を常温で混 合溶解させた A相を調製した。なお、フッ化ナトリウム、モノフルォロリン酸ナトリウムは 、 日本国内で認可される含有量がフッ素イオンとして 1 , OOOppm以下であるため、実 施例ではフッ化ナトリウムは 0. 21%、モノフルォロリン酸ナトリウムは 0. 73%を中心 に配合した。一方、精製水中にポリアクリル酸ナトリウム(レオジック 250H、 日本純薬 (株)製)を常温で分散させた B相を調製した。撹拌中の A相の中に B相を添加混合し 、ポリアクリル酸ナトリウムを膨潤させ、 C相を調製した。更に C相中に、その他の成分 (シルクフイブ口インスクラブ剤、ポリオキシエチレン(20モル)硬化ヒマシ油)等の成分 を 1. 5Lニーダー(有限会社石山工作所製)を用い、常温で混合し、 4kPaまで減圧 し、脱泡を行い、歯磨剤 1. 0kgを得た。  As a method for preparing a dentifrice, A phase was prepared by mixing and dissolving water-soluble components (sodium fluoride, sodium monofluorophosphate, hydrolyzed synolec, cation synolect, pork skin collagen, etc.) in purified water at room temperature. In addition, sodium fluoride and sodium monofluorophosphate have a content approved in Japan of 1, OOOppm or less as fluorine ions, so in the examples sodium fluoride is 0.21% and sodium monofluorophosphate is 0. 73% was compounded mainly. On the other hand, B phase was prepared by dispersing sodium polyacrylate (Rheozic 250H, manufactured by Nippon Pure Chemical Co., Ltd.) in purified water at room temperature. The B phase was added and mixed in the A phase being stirred, and the sodium polyacrylate was swollen to prepare the C phase. In addition, mix ingredients such as other ingredients (silk five mouth inscrubbing agent, polyoxyethylene (20 mol) hydrogenated castor oil), etc. in phase C using a 1.5 L kneader (manufactured by Ishiyama Machine Co., Ltd.) at room temperature. The pressure was reduced to 4 kPa and defoamed to obtain 1.0 kg of a dentifrice.
なお、加水分解シルク、シルクフイブ口イン、豚皮コラーゲンの数平均分子量は、総 窒素量を、化粧品原料基準一般試験法の窒素定量法第一法、アミノ態窒素量をホ ルモール滴定法によって測定し、式(1)により算出した。  The number average molecular weights of hydrolyzed silk, silk fiber mouth-in, and pig skin collagen were determined by measuring the total nitrogen amount, the first nitrogen determination method of the cosmetic raw material standard general test method, and the amino nitrogen amount by the formol titration method. Calculated by the equation (1).
(2)歯磨剤の調製(実施例 8〜: 19) (2) Preparation of dentifrice (Examples 8 to 19)
精製水中に水溶成分 (加水分解シルク、フッ化ナトリウム、モノフルォロリン酸ナトリ ゥム、サッカリンナトリウム、キシリトール、 70%ソルビット等)を常温で混合溶解させた A相を調製した。なお、加水分解シルクは、上記(1)と同様、リン酸加水分解法による 加水分解シルクとしては、数平均分子量 500の(株) NDC製のシルク BN— Pを用い た。リン酸加水分解法以外の加水分解シルクとして、シルクペプチド M— 500 (コスモ 食品(株)製、数平均分子量 500)、プロモイス(登録商標)シノレク ΙΟΟΟρ ( (株)成和 化成製、数平均分子量 1 , 000)、シノレクペプチド 5 (カネボウ (株)製、数平均分子量 1 , 500)、シルクパウダー FD (カネボウ(株)製、数平均分子量 5, 000)を用いた。更 にフッ化ナトリウム、モノフルォロリン酸ナトリウムは、 日本国内で認可される含有量が フッ素イオンとして 1 , OOOppm以下であるため、実施例ではフッ化ナトリウムは 0. 21 %、モノフルォロリン酸ナトリウムは 0. 73%を中心に配合した。一方、プロピレンダリ コール中に、トリクロサン、イソプロピルメチルフエノール、チモール、ポリアクリル酸ナ トリウム(レオジック 250H、 日本純薬(株)製)、キサンタンガム、カルボキシメチルセ ルロースナトリウム等を常温で溶解.分散させた B相を調製した。次に、撹拌中の A相 の中に B相を添加混合し、更にポリオキシエチレン硬化ヒマシ油を配合する実施例に ついては添加混合し、 C相を調製した。 C相中に、香料、無水ケィ酸、その他の成分 ( デキストラナーゼ、ラウリル硫酸ナトリウム等)を、 1. 5Lニーダー(有限会社石山工作 所製)を用い常温で混合し、 4kPaまで減圧し脱泡を行い、歯磨剤 1. Okgを得た。 A phase was prepared by mixing and dissolving water-soluble components (hydrolyzed silk, sodium fluoride, sodium monofluorophosphate, sodium saccharin, xylitol, 70% sorbite, etc.) in purified water at room temperature. As for the hydrolyzed silk, as in (1) above, silk BN-P manufactured by NDC Co., Ltd. having a number average molecular weight of 500 was used as the hydrolyzed silk by the phosphoric acid hydrolysis method. Silk peptide M-500 (Cosmo Foods Co., Ltd., number average molecular weight 500), Promois (registered trademark) Synolec ΙΟΟΟρ (Seiwa Kasei Co., Ltd., number average molecular weight) as hydrolyzed silk other than the phosphate hydrolysis method 1, 000), Synolecpeptide 5 (manufactured by Kanebo Co., Ltd., number average molecular weight 1,500), and silk powder FD (manufactured by Kanebo Co., Ltd., number average molecular weight 5,000) were used. In addition, sodium fluoride and sodium monofluorophosphate have a content approved in Japan of 1, OOOppm or less as fluorine ions. Therefore, in the examples, sodium fluoride is 0.21% and sodium monofluorophosphate is 0.73%. It mix | blended focusing on%. On the other hand, triclosan, isopropylmethylphenol, thymol, and polyacrylic acid in propylene glycol. Phase B was prepared by dissolving and dispersing thorium (Rheology 250H, manufactured by Nippon Pure Chemicals Co., Ltd.), xanthan gum, sodium carboxymethylcellulose and the like at room temperature. Next, the B phase was added and mixed into the A phase being stirred, and the C phase was prepared by adding and mixing the examples in which polyoxyethylene hydrogenated castor oil was blended. In Phase C, fragrance, anhydrous carboxylic acid, and other ingredients (dextranase, sodium lauryl sulfate, etc.) are mixed at room temperature using a 1.5 L kneader (manufactured by Ishiyama Kogyo Co., Ltd.), depressurized to 4 kPa and removed. Foaming was performed to obtain a dentifrice 1. Okg.
[0031] (3)洗口剤の調製 (実施例 20, 21) [0031] (3) Preparation of mouthwash (Examples 20 and 21)
スリーワンモーターと回転羽根を有する撹拌機を装着したステンレス製容器に、規 定量の精製水を投入し、配合成分のうち加水分解シルクなどの水溶性成分を撹拌し ながら投入、溶解させた。一方、スリーワンモーターと回転羽根を有する撹拌機を装 着した別のステンレス製容器に、規定量のエタノール等の有機溶剤を投入し、配合 成分のうち油溶性成分を撹拌しながら投入、溶解させた。更に、水溶性成分を溶解さ せた容器に、上記油溶性成分を加え、 1分〜 30分撹拌し、均一溶液とし、洗口剤を 得た。  A specified amount of purified water was charged into a stainless steel container equipped with a three-one motor and a stirrer having rotating blades, and water-soluble components such as hydrolyzed silk among the blended components were charged and dissolved. On the other hand, in a separate stainless steel container equipped with a three-one motor and a stirrer with rotating blades, a specified amount of an organic solvent such as ethanol was added, and the oil-soluble component of the blended components was added and dissolved while stirring. . Furthermore, the oil-soluble component was added to a container in which the water-soluble component was dissolved, and the mixture was stirred for 1 to 30 minutes to obtain a uniform solution to obtain a mouthwash.
[0032] (4)象牙質コラーゲン分解抑制実験  [0032] (4) Dentin collagen degradation inhibition experiment
JM, Ten Cateらの文献 (The influence of the organic matrix on de mineralization of bovine root dentin in vitro, Journal of Dental R esearch 73 (9): pl 523— 1529, September, 1994)を参考に、牛歯象牙 質コラーゲンの分解試験を行った。  Bovine ivory with reference to JM, Ten Cate et al. (The influence of the organic matrix on de mineralization of bovine root dentin in vitro, Journal of Dental Research 73 (9): pl 523-1529, September, 1994) A collagen collagen degradation test was conducted.
具体的には、健康なゥシから抜去した切歯の根面象牙質を切り出し、縦 5mm X横 5mm X高さ 3mmの象牙質ブロックを作製した。更にブロックの一表面を # 4000の 耐水研磨紙で鏡面研磨し、その面のうち 2mm X 2mmの部分を除き、市販のネイル バー二ッシュを全ての面に塗布し、大きさ 2mm X 2mmの被験面(ウィンドウ部)を作 製した。この被験面を 0. 1M酢酸 (pH5. 0)で、 2日間脱灰し、深さ約 300 x mの脱 灰層、即ちコラーゲン層を得た。  Specifically, the root dentin of the incisor extracted from a healthy ushi was cut out, and a dentin block measuring 5 mm in length, 5 mm in width, and 3 mm in height was produced. In addition, one surface of the block is mirror-polished with # 4000 water-resistant abrasive paper, except for the 2mm X 2mm portion of the surface, a commercial nail burnish is applied to all surfaces, and the test is 2mm X 2mm in size. Surface (window) was made. This test surface was decalcified with 0.1 M acetic acid (pH 5.0) for 2 days to obtain a demineralized layer having a depth of about 300 × m, that is, a collagen layer.
[0033] 実施例:!〜 19及び比較例:!〜 6のモデル歯磨剤'歯磨剤は、ヒト使用下での用法容 量を考慮し蒸留水で 3倍希釈し、その希釈液を処理液とした。また、実施例 20, 21の 洗口剤については、原液を処理液とした。 上記牛歯象牙質ブロックの被験面を各実施例及び比較例の処理液に 3分間、室温 で浸漬し、歯磨剤については用法容量を考慮し蒸留水でよく濯いだ後、洗口剤につ いては蒸留水で濯がず、 Clostridium histolyticum由来のコラゲナーゼ(Type VII, Sigma製)溶液(400単位 ZmL 50mMHEPES, pH7. 8)で 18時間処理し た。この処理を 3回繰返した後、マイクロカッター(MC_ 201、マルトー(株)製)にて 被験面に対し垂直方向に厚さ約 200 μ mの切片を切り出し、ウエット状態のプレパラ ートを作製した。 [0033] Examples:! To 19 and comparative examples:! To 6 model dentifrice 'dentifrice is diluted 3 times with distilled water in consideration of the usage capacity under human use, and the diluted solution is treated liquid. It was. For the mouth washes of Examples 20 and 21, the stock solution was used as the treatment solution. The test surface of the bovine dentin block is immersed in the treatment solution of each example and comparative example for 3 minutes at room temperature, and the dentifrice is rinsed thoroughly with distilled water in consideration of the usage volume, and then used as a mouthwash. Then, it was not rinsed with distilled water, but treated with a collagenase (Type VII, Sigma) solution (400 units ZmL 50 mM HEPES, pH 7.8) derived from Clostridium histolyticum for 18 hours. After repeating this treatment three times, a section with a thickness of about 200 μm was cut out in a direction perpendicular to the test surface with a microcutter (MC_201, manufactured by Marto Co., Ltd.) to prepare a wet preparation. .
最後に、偏光顕微鏡 (BH_ 2、ォリンパス光学工業 (株)製)にて各切片のコラーゲ ン分解層の画像を取得し、画像解析装置 (PIAS _V、ピアス (株)製)でコラーゲン分 解深さ( μ m)を求めた。更にコラーゲン分解処理のみを行ったサンプルの平均コラ 一ゲン分解深さを基準に、各実施例及び比較例のコラーゲン分解抑制率を算出した (下記式(2) )。なお、一連の実験操作は、各実施例及び比較例につき N = 3で行い 、その平均値を示した。象牙質コラーゲン分解抑制効果の評価基準は以下の通りで あった。  Finally, images of the collagen degradation layer of each section were acquired with a polarizing microscope (BH_2, Olympus Optical Co., Ltd.), and the collagen decomposition depth was obtained with an image analyzer (PIAS_V, Pierce Co., Ltd.). (Μm) was obtained. Furthermore, the collagen degradation inhibition rate of each Example and Comparative Example was calculated based on the average collagen degradation depth of samples subjected to only collagen degradation treatment (the following formula (2)). A series of experimental operations were performed with N = 3 for each of the examples and comparative examples, and the average value was shown. The evaluation criteria for the dentin collagen degradation inhibitory effect were as follows.
[0034] [数 2] [0034] [Equation 2]
象牙質コラーゲン 抑制率 =  Dentin collagen inhibition rate =
(無処理群のコラーゲン分解深さ) 一 (実施例 · tt ^例のコラーゲン 深さ)  (Collaboration depth of untreated group) I (Example · tt ^ Collagen depth of example)
X 1 0 0 無処理群のコラーゲン分角深さ  X 1 0 0 Untreated group collagen arc depth
(2 ) 評価基準; 象牙質コラーゲン分解抑制率が、  (2) Evaluation criteria: Dentin collagen degradation inhibition rate is
◎ : 80%以上  ◎: 80% or more
〇〜◎: 60%以上 80%未満  ○ ~ ◎: 60% or more, less than 80%
〇 :40%以上 60%未満  〇: 40% or more and less than 60%
△ : 20%以上 40%未満  △: 20% or more and less than 40%
X : 20%未満  X: Less than 20%
[0035] 実験 2 :人工プラークを用いた健全象牙晳脱灰抑制実験 [0035] Experiment 2: Experiments on suppression of healthy ivory decalcification using artificial plaque
[実施例:!〜 21、比較例:!〜 6]  [Example:! -21, Comparative example:! -6]
この実験は、象牙質表面への原因菌の吸着、原因菌の糖代謝による酸産生、原因 菌の各種酵素の産生などによる総合的な脱灰現象を評価するものであり、より実際の ヒトの口腔内環境に近い評価実験として行った。実験 1と同様にして、健康なゥシから 抜去した切歯の根面象牙質を切り出し、縦 5mm X横 5mm X高さ 3mmの象牙質ブ ロックを作製した。更にブロックの一表面を # 4000の耐水研磨紙で鏡面研磨し、そ の面のうち 2mm X 2mmの部分を除き、市販のネイルバー二ッシュを全ての面に塗 布し、大きさ 2mm X 2mmの被験面(ウィンドウ部)を作製した。このサンプルをコバル ト 60ガンマ線照射により、 10. 4kj/kgの線量で滅菌処理を行った。 In this experiment, the causative bacteria are adsorbed on the dentin surface, the acid production by the sugar metabolism of the causative bacteria, the cause This was to evaluate the comprehensive demineralization phenomenon due to the production of various enzymes of the fungus, and was conducted as an evaluation experiment closer to the actual human oral environment. In the same manner as in Experiment 1, the root surface dentin of the incisor extracted from a healthy ushi was cut out to produce a dentin block 5 mm long x 5 mm wide x 3 mm high. Furthermore, one surface of the block is mirror-polished with # 4000 water-resistant abrasive paper, except for the 2mm X 2mm portion of the surface, and a commercial nail burnish is applied to all sides, and the size is 2mm X 2mm. A test surface (window portion) was prepared. This sample was sterilized by irradiation with cobalt 60 gamma rays at a dose of 10.4 kj / kg.
用いる製剤は、実験 1で調製した、モデル歯磨剤、歯磨剤及び洗口剤をそのまま使 用した。実施例:!〜 19及び比較例:!〜 6のモデル歯磨剤、歯磨剤については、蒸留 水で 3倍希釈し、遠心機(日立 05PR_ 22、 日立ェ機 (株)製)にて 3, OOOrpm、室 温で 10分間遠心した上清液を、更に細孔径 0. 22 z mのフィルター(Millex— GS、 日本ミリポア (株)製)でろ過滅菌を行レ、、それを処理液とした。また、実施例 20, 21 については洗口剤のため、原液をろ過滅菌したものを処理液とした。  The model dentifrice, dentifrice, and mouthwash prepared in Experiment 1 were used as they were. Examples:! To 19 and comparative examples:! To 6 model dentifrices and dentifrices were diluted three-fold with distilled water, and centrifuge (Hitachi 05PR_22, manufactured by Hitachi Eki Co., Ltd.) 3, The supernatant obtained by centrifugation at OOOrpm and room temperature for 10 minutes was further sterilized by filtration through a filter having a pore size of 0.22 zm (Millex-GS, manufactured by Nihon Millipore Co., Ltd.), and this was used as a treatment solution. In Examples 20 and 21, since the mouthwash was used, a solution obtained by sterilizing the stock solution by filtration was used.
次に、上記牛歯象牙質ブロックの被験面を各実施例及び比較例の処理液に 3分間 、室温で浸漬し、滅菌蒸留水でよく濯いだ後、う蝕原因菌であるミュータンス菌(Stre ptococcus mutans ATCC25175)を含む THB (Todd Hewitt Broth, Difc o製)培地 1. 5mLに投入し、 37°C、嫌気状態で 1日培養し、象牙質ブロックの被験 面表面に人工プラークを形成させた。この場合、実施例 20, 21については、洗口剤 のため、減菌蒸留水による濯ぎはしなかった。その後、象牙質ブロックを取り出し、人 ェプラークが形成された被験面に、再度各実施例及び比較例の処理液を 3分間、室 温で浸漬させ、滅菌蒸留水でよく濯いだ後、 1%ショ糖を含む THB培地 1. 5mLに 投入し、 37°C、嫌気状態で 1日培養した。この場合も、実施例 20, 21については、 洗口剤のため、滅菌蒸留水による濯ぎはしなかった。この処理を 1日 1回、計 4日間 繰返した。なお、薬剤処理した後浸漬する培地は毎回新しいものを使用した。このあ と、被験面の人工プラークを筆で注意深く除去し、マイクロカッター(MC— 201、マ ノレトー(株)製)にて被験面に対して垂直方向になるように厚さ約 200 μ mの切片を流 水下で注意深く切り出した。更に、ウエット状態で、軟 X線発生装置(CMRII、ソフテ ックス (株)製)により、軟 X線用フィルム(SO— 343、コダック社製)上に 2. 8mA、 18 kVp、 60分照射し、各切片の TMR (Transverse Micro Radiography)像を取得 した。 Next, after immersing the test surface of the bovine dentin block in the treatment solution of each Example and Comparative Example for 3 minutes at room temperature and rinsing well with sterilized distilled water, the mutans bacteria that are caries-causing bacteria THB (Todd Hewitt Broth, Difco) medium containing (Stre ptococcus mutans ATCC25175) 1. Add to 5 mL and incubate at 37 ° C for 1 day under anaerobic conditions to form artificial plaque on the surface of dentin block I let you. In this case, Examples 20 and 21 were not rinsed with sterilized distilled water because of the mouthwash. Thereafter, the dentin block was taken out, and the treatment solution of each Example and Comparative Example was again immersed in the test surface on which the human plaque was formed for 3 minutes at room temperature, rinsed well with sterile distilled water, and then 1% THB medium containing sucrose was added to 1.5 mL and cultured at 37 ° C for 1 day under anaerobic conditions. Also in this case, Examples 20 and 21 were not rinsed with sterilized distilled water because of the mouthwash. This treatment was repeated once a day for a total of 4 days. In addition, the culture medium immersed after chemical | medical agent treatment used the new thing each time. After that, carefully remove the artificial plaque on the test surface with a brush, and use a microcutter (MC-201, manufactured by Manoleto Co., Ltd.) to make the test plate approximately 200 μm thick so that it is perpendicular to the test surface. Sections were carefully cut under running water. Furthermore, with a soft X-ray generator (CMRII, manufactured by Softex Co., Ltd.) in a wet state, 2.8 mA, 18 on the soft X-ray film (SO-343, manufactured by Kodak). Irradiated with kVp for 60 minutes, a TMR (Transverse Micro Radiography) image of each section was obtained.
最後に、各切片の脱灰程度を、切片とともに撮影した 15枚のアルミニウムステップ ゥェッジの TMR像から、画像解析装置(PIAS _V、ピアス (株)製)により各 TMR像 に対するミネラルプロファイルを描き、ミネラル喪失量 Δ Ζ (脱灰量)を算出した。更に 薬剤処理しなレ、 (培養のみ)サンプルの平均 Δ Zを基準脱灰量とし、各実施例及び比 較例の象牙質脱灰抑制率を算出した(下記式 (3) )。なお一連の実験操作は、各実 施例及び比較例につき N = 3で行レ、、その平均値を示した。評価基準は以下の通り であった。  Finally, the demineralization degree of each section was drawn from the TMR images of 15 aluminum step wedges taken together with the sections, and the mineral profile for each TMR image was drawn using an image analyzer (PIAS_V, manufactured by Pierce Co., Ltd.). The amount of loss Δ Ζ (decalcification amount) was calculated. Furthermore, the delta dentin demineralization suppression rate of each Example and the comparative example was calculated by using the average ΔZ of the sample without treatment with the drug as the reference decalcification amount (the following formula (3)). In the series of experimental operations, N = 3 for each example and comparative example, and the average value was shown. The evaluation criteria were as follows.
[0037] [数 3]  [0037] [Equation 3]
象牙質脱灰抑制率 (%) =  Dentin demineralization inhibition rate (%) =
(無処理群の平均 ^ Ζ ) - (実施例,比較例の平均 Z )  (Average of untreated group ^ Ζ)-(Average Z of Examples and Comparative Examples)
X 1 0 0 ( 3 ) 無処理群の平均  X 1 0 0 (3) Average of untreated group
評価基準; 象牙質の脱灰抑制率が、  Evaluation criteria: Dentin demineralization inhibition rate is
◎ : 70%以上  : 70% or more
〇: 50%以上 70%未満  ○: 50% or more and less than 70%
△ : 30%以上 50%未満  △: 30% or more and less than 50%
X: 30%未満  X: Less than 30%
[0038] 実施例:!〜 7及び比較例:!〜 6の評価結果については表 1にまとめた。実施例 8〜2 The evaluation results of Examples:! To 7 and Comparative Examples:! To 6 are summarized in Table 1. Examples 8-2
1の評価結果については表 2にまとめた。 The evaluation results for 1 are summarized in Table 2.
[0039] [表 1] [0039] [Table 1]
比 比 比 比 比 比 施 施 施 較 較 較 較 較 例 例 例 例 例 Ratio Ratio Ratio Ratio Ratio Application Application Comparison Comparison Example Example Example Example
1 2 3 4 I D 7 1 2 3 4 f 6 加水分解シルク *1  1 2 3 4 I D 7 1 2 3 4 f 6 Hydrolyzed silk * 1
1 2 1.5 1  1 2 1.5 1
(数平均分子量 500)  (Number average molecular weight 500)
加水分解シルタ *2  Hydrolyzed silta * 2
1  1
(数平均分子量 500)  (Number average molecular weight 500)
カロ水分解シ/  Karo water splitting /
1  1
(数平均分子量 1,000)  (Number average molecular weight 1,000)
カロ水分解シルク  Karo water splitting silk
1  1
(数平均分子量 1,500)  (Number average molecular weight 1,500)
力 DTK分解シルク  DTK decomposition silk
1  1
(数平均分子量 5,000)  (Number average molecular weight 5,000)
7%シルクフイブ πイン ί 夜  7% silk hive π in ί night
20  20
(数平均分子量 35万)  (Number average molecular weight 350,000)
シルクフィフ '口イン  Silk Fif 'Mouth Inn
2  2
(スクラブ剤)  (Scrub agent)
豚皮コラーケ'ン  Pork skin
1.5  1.5
(数平均分子量 40万)  (Number average molecular weight 400,000)
力チ才ン化シルク 7.5 フッ化ナトリウム 0.21 0.21 0.21 0.21 0.21 0,21 0.21 0,21 0.21 0.21 0.21 モノフル才 tiリン酸ナトリウム 0.73  Vitalized silk 7.5 Sodium fluoride 0.21 0.21 0.21 0.21 0.21 0,21 0.21 0,21 0.21 0.21 0.21 Monoful ti sodium phosphate 0.73
ホ'リ才キシエチレン  Hori's old xylene
0.7 (20モル)硬化ヒマシ油  0.7 (20 mol) hydrogenated castor oil
ホ'リアクリル酉針トリウム 0.9 0.9 0.9 0.9 0.9 0,9 0.9 0.9 0.9 0.9 0,9 0.9 0.9 精製水 残 残 残 残 残 残 残 残 残 残 残 残 残 ム^ 100 100 100 100 100 100 100 100 100 100 100 100 100 象 a¾コラ-ゲン  Polyacrylic needle thorium 0.9 0.9 0.9 0.9 0.9 0.9 0,9 0.9 0.9 0.9 0.9 0,9 0.9 0.9 Purified water Residue Residue Residue Residue Residual Residual Residue Residual Residual Residue Residue ^ 100 100 100 100 100 100 100 100 100 100 100 100 100 Elephant a¾ Collagen
o〜® 〇 〇 〇 〇〜© 〇〜© X Δ Δ X  o ~ ® 〇 〇 〇 〇 ~ © 〇 ~ © X Δ Δ X
^军抑制効果 △ △ 象 質 抑制効果 〇 〇 o 〇 〇 o 〇 △ X △ △ △ △  ^ 军 Suppressive effect △ △ Quality control effect ○ ○ o ○ ○ o ○ △ X △ △ △ △
* 1 リン酸加水分解法によるシルク BN— P * 1 Silk BN—P by phosphoric acid hydrolysis method
* 2 酵素加水分解法によるシルクペプチド M_ 500  * 2 Silk peptide M_ 500 by enzymatic hydrolysis method
実施例 1〜7のように、数平均分子量が 500〜5, 000の加水分解シルクとフッ素化 合物を含有するものについては、優れた象牙質コラーゲン分解抑制効果及び脱灰 抑制効果を示した。その中で、特に数平均分子量 500〜: 1, 000の加水分解シノレクと フッ素化合物とを含有するものが高い象牙質コラーゲン分解抑制効果を示した。また 、同じ数平均分子量の加水分解シルクの効果を比較した場合、特にリン酸加水分解 した加水分解シルクとフッ素化合物とを含有するものの方が、リン酸で加水分解して いない加水分解シルクとフッ素化合物とを含有するものよりも高い象牙質コラーゲン 分解抑制効果を示した。これは、リン酸加水分解した加水分解シルクの方が、ぺプチ ド含量が高いためと推測された。一方、比較例のように加水分解シルクのみ、フッ素 化合物のみの場合、あるいは、カチオン化シルクや数平均分子量のかなり大きなシ ルクフイブ口インやコラーゲンを含有する場合は、象牙質のコラーゲン分解抑制効果 や脱灰抑制効果は十分な効果が得られなかった。 As in Examples 1 to 7, those containing hydrolyzed silk and fluorine compounds having a number average molecular weight of 500 to 5,000 showed excellent dentin collagen degradation inhibitory effect and demineralization inhibitory effect. . Among them, especially those containing hydrolyzed synolec having a number average molecular weight of 500 to 1,000 and a fluorine compound showed a high inhibitory effect on dentin collagen degradation. In addition, when the effects of hydrolyzed silk having the same number average molecular weight are compared, the hydrolyzed silk that has been hydrolyzed with phosphoric acid and the fluorine compound are particularly those containing hydrolyzed silk that has not been hydrolyzed with phosphoric acid and fluorine. Dentin collagen higher than that containing the compound Degradation inhibitory effect was shown. This is presumably because hydrolyzed silk that had been hydrolyzed with phosphoric acid had a higher peptide content. On the other hand, when only hydrolyzed silk or only fluorine compounds are used as in the comparative examples, or when cationized silk or a silk fiber mouth-in or collagen having a considerably large number average molecular weight is contained, the dentin collagen degradation inhibitory effect or The decalcification inhibitory effect was not sufficient.
[0041] [実施例 8]歯磨剤  [0041] [Example 8] Dentifrice
無水ケィ酸 15. 0  Caustic anhydride 15.0
フツイ匕ナトリウム 0. 21  Futsui Sodium 0.21
加水分解シルク (数平均分子量: 500) 1. 0  Hydrolyzed silk (Number average molecular weight: 500) 1.0
(シルク BN_P、(株) NDC製)  (Silk BN_P, NDC)
ラウリル硫酸ナトリウム 0. 1  Sodium lauryl sulfate 0.1
ポリアクリル酸ナトリウム 0. 8  Sodium polyacrylate 0.8
キサンタンガム 0. 3  Xanthan gum 0.3
香料 0. 1  Fragrance 0. 1
精製水  purified water
計 100. 0 %  Total 100.0%
[0042] [実施例 9]歯磨剤  [Example 9] Dentifrice
無水ケィ酸 15. 0  Caustic anhydride 15.0
フツイ匕ナトリウム 0. 21  Futsui Sodium 0.21
加水分解シルク (数平均分子量: 500) 1. 0  Hydrolyzed silk (Number average molecular weight: 500) 1.0
(シノレクペプチド M— 500、コスモ食品(株)製)  (Synolecpeptide M-500, manufactured by Cosmo Foods Co., Ltd.)
ラウリル硫酸ナトリウム 0. 1  Sodium lauryl sulfate 0.1
ポリアクリル酸ナトリウム 0. 8  Sodium polyacrylate 0.8
キサンタンガム 0. 3  Xanthan gum 0.3
香料 0. 1  Fragrance 0. 1
精 m  Cum m
計 100. 0 %  Total 100.0%
[0043] [実施例 10]歯磨剤 無水ケィ酸 15. 0 フッ化ナ卜リウム 0. 21 加水分解シルク(数平均分子量: 5, 000) 1. 0 (シノレクパウダー FD、カネボウ(株)製) [0043] [Example 10] Dentifrice Caustic anhydride 15.0 Sodium fluoride 0.21 Hydrolyzed silk (number average molecular weight: 5,000) 1.0 (Sinorek powder FD, Kanebo Co., Ltd.)
ラウリル硫酸ナトリウム 0. 1 ポリアクリル酸ナトリウム 0. 8 キサンタンガム 0. 8 サッカリンナトリウム 0. 02 香料 0. 1 精製水 m 計 100. 0 % Sodium lauryl sulfate 0.1 Sodium polyacrylate 0.8 Xanthan gum 0.8 8 Saccharin sodium 0.02 Fragrance 0.1 Purified water m Total 100.0%
[0044] [実施例 11]歯磨剤 [0044] [Example 11] Dentifrice
無水ケィ酸 15. 0 フッ化ナトリウム 0· 21 加水分解シルク (数平均分子量: 1 , 000) 1. 0 (プロモイス(登録商標)シルク 1 OOOp、 (株)成和化成製) ラウリル硫酸ナトリウム 0· 1 ポリアクリル酸ナトリウム 0· 5 カルボキシメチルセルロースナトリウム 0· 3 キサンタンガム 0· 5 キシリトール 9. 0 クェン酸ナトリウム 0. 3 香料 0. 1 精製水 m 計 100. 0 % Caustic anhydride 15. 0 Sodium fluoride 0 · 21 Hydrolyzed silk (Number average molecular weight: 1, 000) 1.0 (Promois® silk 1 OOOp, manufactured by Seiwa Kasei Co., Ltd.) Sodium lauryl sulfate 0 · 1 Sodium polyacrylate 0 · 5 Sodium carboxymethylcellulose 0 · 3 Xanthan gum 0 · 5 Xylitol 9.0 Sodium citrate 0.3 Fragrance 0.1 Purified water m Total 100.0%
[0045] [実施例 12]歯磨剤 [0045] [Example 12] Dentifrice
無水ケィ酸 15. 0 フッ化ナトリウム 0. 21 加水分解シルク (数平均分子量: 1, 500) 1. 0 (シルクペプチド5、カネボウ(株)製) Caustic anhydride 15.0 Sodium fluoride 0.21 Hydrolyzed silk (Number average molecular weight: 1,500) 1.0 (Silk peptide 5 , manufactured by Kanebo Corporation)
ラウリル硫酸ナトリウム 0. 1 ポリアクリル酸ナトリウム 0. 3 カルボキシメチルセルロースナトリウム 0. 5 キサンタンガム 0. 8 キシリトール 2. 0 デキストラナーゼ 0. 3 香料 0. 1  Sodium lauryl sulfate 0.1 Poly sodium acrylate 0.3 Sodium carboxymethyl cellulose 0.5 Xanthan gum 0.8 Xylitol 2.0 Dextranase 0.3 Fragrance 0.1
精製水 m 計 100. 0 %  Purified water m Total 100. 0%
[0046] [実施例 13]歯磨剤  [0046] [Example 13] Dentifrice
フッ化ナトリウム 0· 21 加水分解シルク (数平均分子量: 500) 1. 0 (シルク BN— P、(株) NDC製)  Sodium fluoride 0 · 21 Hydrolyzed silk (Number average molecular weight: 500) 1.0 (Silk BN—P, manufactured by NDC)
卜リク口サン 0. 05 ポリオキシエチレン(20モル)硬化ヒマシ油 1. 4 ラウリル硫酸ナトリウム 1 · 0 卜 Lique mouth sun 0. 05 Polyoxyethylene (20 mol) hydrogenated castor oil 1.4 Sodium lauryl sulfate 1 · 0
70%ソノレビット 40. 0 プロピレングリコール 5. 0 ポリアクリル酸ナトリウム 0. 8 カルボキシメチルセルロースナトリウム 0. 4 キサンタンガム 0. 4 香料 0. 5 70% Sonorebit 40.0 Propylene glycol 5.0 Sodium polyacrylate 0.8 Sodium carboxymethylcellulose 0.4 Xanthan gum 0.4 Perfume 0.5
精製水 m 計 100. 0 %  Purified water m Total 100. 0%
[0047] [実施例 14]歯磨剤  [0047] [Example 14] Dentifrice
フッ化ナトリウム 0. 21 加水分解シルク (数平均分子量: 500) 1. 0 (シルク BN— P、(株) NDC製) Sodium fluoride 0.21 Hydrolyzed silk (Number average molecular weight: 500) 1.0 (Silk BN—P, manufactured by NDC)
イソプロピルメチルフエノール 0, 05 ポリオキシエチレン(20モル)硬化ヒマシ油 1. 4 ラウリル硫酸ナトリウム 1. 0Isopropylmethylphenol 0, 05 Polyoxyethylene (20 mol) hydrogenated castor oil 1.4 Sodium lauryl sulfate 1.0
70%ソノレビット 40. 0 プロピレングリコーノレ 5. 0 ポリアクリル酸ナトリウム 0. 4 カルボキシメチルセルロースナトリウム 0. 2 キサンタンガム 0. 2 香料 0. 5 70% Sonorebit 40.0 Propylene Glycolol 5.0 Sodium Polyacrylate 0.4 Sodium Carboxymethyl Cellulose 0.2 Xanthan Gum 0.2 Fragrance 0.5
精 B B
計 100. 0 % [実施例 15]歯磨剤  Total 100. 0% [Example 15] Dentifrice
無水ケィ酸 15. 0 フッ化ナトリウム 0. 21 加水分解シルク (数平均分子量: 500) 1. 0 (シルク BN— P、(株) NDC製) Caustic anhydride 15. 0 Sodium fluoride 0.21 Hydrolyzed silk (Number average molecular weight: 500) 1.0 (Silk BN—P, manufactured by NDC)
チモール 0. 05 ポリオキシエチレン(20モル)硬化ヒマシ油 1 · 4 ラウリル硫酸ナトリウム 1. 0Thymol 0. 05 Polyoxyethylene (20 mol) hydrogenated castor oil 1 · 4 Sodium lauryl sulfate 1.0
70%ソルビット 40. 0 プロピレングリコーノレ 5. 0 ポリアクリル酸ナトリウム 0. 5 キサンタンガム 0. 8 キシリトーノレ 9. 0 香料 0. 5 70% Sorbit 40.0 Propylene Glycolol 5.0 Sodium Polyacrylate 0.5 Xanthan Gum 0.8 Xylitoleol 9.0 Perfume 0.5
精 B 計 100. 0 % B Total 100.0%
[0049] [実施例 16]歯磨剤  [0049] [Example 16] Dentifrice
フッ化ナトリウム 0. 21 加水分解シルク(数平均分子量: 500) 1. 0 (シルク BN_P、(株) NDC製)  Sodium fluoride 0.21 Hydrolyzed silk (Number average molecular weight: 500) 1.0 (Silk BN_P, manufactured by NDC)
卜リク口サン 0. 05 イソプロピルメチルフエノール 0. 05 ポリオキシエチレン(20モル)硬化ヒマシ油 1. 4 ラウリル硫酸ナトリウム 1. 0 卜 Lique mouth sun 0.05 Alcohol methylphenol 0.05 Alcohol (20 mol) hydrogenated castor oil 1.4 Sodium lauryl sulfate 1.0
70%ソルビット 40. 0 プロピレングリコール 5. 0 ポリアクリル酸ナトリウム 0. 8 カルボキシメチルセルロースナトリウム 0· 8 水酸化ナトリウム 0. 3 サッカリンナトリウム 0. 05 キシリトール 9. 0 香料 0. 5 70% sorbit 40.0 propylene glycol 5.0 sodium polyacrylate 0.8 sodium carboxymethyl cellulose 0.8 sodium hydroxide 0.3 sodium saccharin 0.05 xylitol 9.0 perfume 0.5
精製水  purified water
計 100. 0 %  Total 100.0%
[0050] [実施例 17]歯磨剤  [0050] [Example 17] Dentifrice
第二リン酸カルシウム 15. 0 モノフルォロリン酸ナトリウム 0. 73 加水分解シルク (数平均分子量: 500) 1. 0 (シルク BN— P、(株) NDC製)  Dicalcium phosphate 15. 0 Sodium monofluorophosphate 0.73 Hydrolyzed silk (Number average molecular weight: 500) 1.0 (Silk BN—P, manufactured by NDC)
卜リク口サン 0. 03 ポリオキシエチレン(20モル)硬化ヒマシ油 1. 2 ラウリル硫酸ナトリウム 0. 8 卜 Lique mouth sun 0.03 Polyoxyethylene (20 mol) hydrogenated castor oil 1.2 Sodium lauryl sulfate 0.8
70%ソノレビット 40. 0 プロピレングリコール 5. 0 ポリアクリル酸ナトリウム 0· 5 カノレボキシメチルセノレロースナトリウム 0. 5 水酸化ナトリウム 0. 3 サッカリンナトリウム 0. 05 キシリトール 9. 0 香料 0. 5 精 m 計 100. 0 %70% Sonorbit 40. 0 Propylene glycol 5.0 Sodium polyacrylate 0.5 Sodium sodium canoleoxymethyl senorelose 0.5 Sodium hydroxide 0.3 Sodium saccharin 0.5 05 Xylitol 9.0 Fragrance 0.5 Total semen 100. 0%
[0051] [実施例 18]歯磨剤 [0051] [Example 18] Dentifrice
フッ化ナトリウム 0. 4 加水分解シルク(数平均分子量: 500) 0. 5 (シルク BN— P、(株) NDC製)  Sodium fluoride 0.4 Hydrolyzed silk (Number average molecular weight: 500) 0.5 (Silk BN—P, manufactured by NDC)
イソプロピルメチルフエノール 0. 05 ポリオキシエチレン(20モル)硬化ヒマシ油 1 · 4 ラウリル硫酸ナトリウム 0· 5 Isopropylmethylphenol 0.05 0.05 Polyoxyethylene (20 mol) hydrogenated castor oil 1 · 4 Sodium lauryl sulfate 0 · 5
70%ソノレビット 30. 0 プロピレングリコール 5. 0 ポリアクリル酸ナトリウム 0· 5 水酸化ナトリウム 0· 3 サッカリンナトリウム 0· 05 デキストラナーゼ 0. 3 香料 0. 5 精 m 計 100. 0 %70% Sonorbit 30.0 Propylene glycol 5. 0 Sodium polyacrylate 0.5 Sodium hydroxide 0.3 Sodium saccharin 0.05 Dextranase 0. 3 Fragrance 0.5 0.5 Total m 100.0%
[0052] [実施例 19]歯磨剤 [0052] [Example 19] Dentifrice
無水ケィ酸 15. 0 フッ化ナトリウム 0. 21 加水分解シルク(数平均分子量: 500) 2. 0 (シルク BN— P、(株) NDC製) Caustic anhydride 15.0 Sodium fluoride 0.21 Hydrolyzed silk (Number average molecular weight: 500) 2.0 (Silk BN—P, manufactured by NDC)
卜リク口サン 0. 1 ポリオキシエチレン(10モル)硬化ヒマシ油 0. 8 ラウリル硫酸ナトリウム 1. 0卜 Likuguchi Sun 0.1 Polyoxyethylene (10 mol) hydrogenated castor oil 0.8 Sodium lauryl sulfate 1.0
70%ソノレビット 40. 0 プロピレングリコール 5. 0 ポリアクリル酸ナトリウム 0. 8 カルボキシメチルセルロースナトリウム 0. 5 キサンタンガム 0. 3 水酸化ナトリウム 0. 3 サッカリンナトリウム 0. 05 香料 0. 5 70% Sonorebit 40.0 Propylene glycol 5. 0 Sodium polyacrylate 0. 8 Sodium carboxymethylcellulose 0. 5 Xanthan gum 0. 3 Sodium hydroxide 0. 3 Sodium saccharin 0. 05 Fragrance 0. 5
精製水 purified water
計 100. 0 % Total 100.0%
[実施例 20]洗口剤 [Example 20] Mouthwash
加水分解シルク (数平均分子量: 500) 1. 5 (シルク BN— P、(株) NDC製) Hydrolyzed silk (Number average molecular weight: 500) 1.5 (Silk BN—P, manufactured by NDC)
フツイ匕ナトリウム 0. 05 卜リク口サン 0. 02 ポリオキシエチレン(60モル)硬化ヒマシ油 0. 3 エタノーノレ 10. 0 クェン酸 0. 01 クェン酸 3ナトリウム 0. 3 サッカリンナトリウム 0. 1 キシリトール 5. 0Futsui Sodium 0.5.5 Kikuchi Sun San 0.02 Polyoxyethylene (60 mol) hydrogenated castor oil 0.3 Ethanol Nore 10.0 Cenoic acid 0.01 Nacreate 30.3 Sodium saccharin 0.1 0.1 Xylitol 5.0
0. 1%緑色 3号 0. 8 香料 0. 3 精製水 m 0. 1% Green No. 3 0. 8 Fragrance 0. 3 Purified water m
計 100. 0 %  Total 100.0%
[0054] [実施例 21]洗口剤  [0054] [Example 21] Mouthwash
加水分解シルク(数平均分子量: 1, 000) 2. 0  Hydrolyzed silk (number average molecular weight: 1,000) 2.0
(プロモイス(登録商標)シルク 1000p、(株)成和化成製)  (Promois (registered trademark) Silk 1000p, Seiwa Kasei Co., Ltd.)
フツイ匕ナトリウム 0. 05  Futsui sodium 0. 05
イソプロピルメチルフエノール 0. 08  Isopropyl methyl phenol 0. 08
卜リク口サン 0. 05  卜 Rikuguchi Sun 0. 05
ポリオキシエチレン(60モル)硬化ヒマシ油 0. 3  Polyoxyethylene (60 mol) hydrogenated castor oil 0.3
エタノーノレ 10. 0  Ethanore 10. 0
クェン酸 0. 01  Quenic acid 0. 01
クェン酸 3ナトリウム 0. 3  Cenoic acid trisodium 0.3
サッカリンナトリウム 0· 1  Saccharin sodium 0 · 1
デキストラナーゼ 3· 0  Dextranase 3 · 0
0. 1%緑色 3号 0. 8  0. 1% green No. 3 0. 8
香料 0. 3  Fragrance 0.3
精製水  purified water
計 100. 0 %  Total 100.0%
[0055] [表 2]  [0055] [Table 2]
Figure imgf000024_0001
表 2から、数平均分子量が 500〜5, 000の加水分解シルクとフッ素化合物を含有 するものについて、優れた象牙質コラーゲン分解抑制効果及び脱灰抑制効果を示し た。その中で、特に数平均分子量 500〜1, 000の加水分解シルクとフッ素化合物と を含有するものが高い象牙質コラーゲン分解抑制効果を示した。また、同じ数平均 分子量の加水分解シルクの効果を比較した場合、特にリン酸加水分解した加水分解 シノレクとフッ素化合物とを含有するものの方力 リン酸で加水分解してレ、なレ、加水分 解シノレクとフッ素化合物とを含有するものよりも高い象牙質コラーゲン分解抑制効果 を示した。これは、前記同様リン酸加水分解した加水分解シルクの方が、ペプチド含 量が高いためと推測された。更には難水溶性非イオン性抗菌剤とそれを可溶化させ るための界面活性剤及び/又はアルコール類の併用により、象牙質のコラーゲン分 解抑制効果と脱灰抑制効果がより向上し、象牙質のう蝕予防効果を飛躍的に向上さ せることが示唆された。
Figure imgf000024_0001
From Table 2, the dentin collagen degradation inhibitory effect and the demineralization inhibitory effect were excellent for those containing hydrolyzed silk having a number average molecular weight of 500 to 5,000 and a fluorine compound. Among them, in particular, hydrolyzed silk having a number average molecular weight of 500 to 1,000, fluorine compound, The one containing a high dentin collagen degradation inhibitory effect. In addition, when comparing the effects of hydrolyzed silk of the same number average molecular weight, especially those containing phosphoric acid hydrolyzed synolec and fluorine compounds, hydrolyzed with phosphoric acid, hydrolyzed with phosphoric acid, It showed a higher inhibitory effect on dentin collagen degradation than that containing antisynolec and fluorine compounds. This was presumed to be due to the higher peptide content of hydrolyzed silk that had been hydrolyzed with phosphoric acid as described above. Furthermore, the combined use of a poorly water-soluble nonionic antibacterial agent and a surfactant and / or alcohol for solubilizing it further improves the collagen degradation inhibitory effect and decalcification inhibitory effect of the dentin. It was suggested that the quality of caries prevention could be improved dramatically.
上記の実験例から、実施例:!〜 21は、比較例:!〜 6と比較して、短時間処理で象牙 質を保護し、象牙質コラーゲンの分解を効果的に抑制していること、更にはフッ素化 合物や抗菌剤の歯面への滞留性を大幅に向上させていることで、相乗的に高い脱 灰抑制効果を有することが推測された。  From the above experimental examples, Examples:! To 21 protected the dentin in a short time treatment and effectively suppressed the degradation of the dentin collagen, compared with the comparative examples:! Furthermore, it has been speculated that the retention of fluorinated compounds and antibacterial agents on the tooth surface has been greatly improved, resulting in a synergistic high deashing suppression effect.
従って、本発明によれば、特定の数平均分子量の加水分解シルクとフッ素化合物 を用いることにより、象牙質のコラーゲン分解と脱灰を顕著に抑制することができる。 更には難水溶性非イオン性抗菌剤とそれを可溶化させるための界面活性剤及び/ 又はアルコール類を加えることで、象牙質のコラーゲン分解抑制効果と脱灰抑制効 果の双方を向上させることにより、象牙質う蝕の予防効果が飛躍的に向上した口腔 用組成物を提供することができる。  Therefore, according to the present invention, collagen degradation and decalcification of dentin can be remarkably suppressed by using hydrolyzed silk and a fluorine compound having a specific number average molecular weight. Furthermore, by adding a poorly water-soluble nonionic antibacterial agent and a surfactant and / or alcohol to solubilize it, both the collagen degradation inhibitory effect and the demineralization inhibitory effect of dentin are improved. Thus, it is possible to provide a composition for oral cavity in which the effect of preventing dentin caries has been dramatically improved.

Claims

請求の範囲 The scope of the claims
[1] 総窒素量とアミノ態窒素量をもとに計算される数平均分子量が 200〜6, 000の加 水分解シルクと、フッ素化合物とを含有することを特徴とする口腔用組成物。  [1] An oral composition comprising hydrolyzed silk having a number average molecular weight of 200 to 6,000 calculated based on the total nitrogen content and amino nitrogen content, and a fluorine compound.
[2] 加水分解シルクがリン酸加水分解により得られたものである請求項 1記載の口腔用 組成物。  [2] The composition for oral cavity according to claim 1, wherein the hydrolyzed silk is obtained by phosphoric acid hydrolysis.
[3] 加水分解シノレクの配合量が組成物全体の 0. 1〜: 10質量%であり、フッ素化合物の 配合量が組成物全体の 0. 02〜3質量%である請求項 1又は 2記載の口腔用組成物  [3] The amount of hydrolyzed synolec is 0.1 to 10% by mass of the entire composition, and the amount of fluorine compound is 0.02 to 3% by mass of the entire composition. Oral composition
[4] 更に、難水溶性非イオン性抗菌剤と、界面活性剤及び/又はアルコール類を含有 することを特徴とする請求項 1乃至 3のいずれか 1項記載の口腔用組成物。 [4] The composition for oral cavity according to any one of claims 1 to 3, further comprising a slightly water-soluble nonionic antibacterial agent, a surfactant and / or an alcohol.
[5] 難水溶性非イオン性抗菌剤がトリクロサン又はイソピロピルメチルフエノールであり、 界面活性剤が平均付加モル数が 5〜: 100のポリオキシエチレン硬化ヒマシ油又はァ ルキル硫酸エステル塩であり、アルコールがプロピレングリコール、ポリエチレングリコ 一ノレ( # 200〜6000)、エチレングリコール、グリセリン、ソルビトール又はエタノール である請求項 4記載の口腔用組成物。  [5] The poorly water-soluble nonionic antibacterial agent is triclosan or isopropylmethylphenol, and the surfactant is polyoxyethylene hydrogenated castor oil or alkyl sulfate salt having an average addition mole number of 5 to 100. The composition for oral cavity according to claim 4, wherein the alcohol is propylene glycol, polyethylene glycol mononole (# 200 to 6000), ethylene glycol, glycerin, sorbitol or ethanol.
[6] 難水溶性非イオン性抗菌剤の配合量が組成物全体の 0. 0:!〜 2質量%であり、界 面活性剤の配合量が組成物全体の 0.:!〜 5質量%であり、アルコールの配合量が 組成物全体の 0.:!〜 50質量%である請求項 4又は 5記載の口腔用組成物。  [6] The amount of the poorly water-soluble nonionic antibacterial agent is 0.0 :! to 2% by mass of the whole composition, and the amount of the surfactant is 0.:! To 5% of the whole composition. The composition for oral cavity according to claim 4 or 5, wherein the blending amount of alcohol is 0.:! To 50% by mass of the whole composition.
PCT/JP2005/022831 2004-12-22 2005-12-13 Hydrolyzed-silk-containing composition for oral cavity WO2006068001A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
KR1020077013828A KR101293893B1 (en) 2004-12-22 2005-12-13 Hydrolyzed-silk-containing compositions for oral cavity
JP2006548846A JP4826790B2 (en) 2004-12-22 2005-12-13 Oral composition containing hydrolyzed silk
CN2005800463591A CN101098676B (en) 2004-12-22 2005-12-13 Hydrolyzed-silk-containing composition for oral cavity

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2004371205 2004-12-22
JP2004-371205 2004-12-22

Publications (1)

Publication Number Publication Date
WO2006068001A1 true WO2006068001A1 (en) 2006-06-29

Family

ID=36601602

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2005/022831 WO2006068001A1 (en) 2004-12-22 2005-12-13 Hydrolyzed-silk-containing composition for oral cavity

Country Status (4)

Country Link
JP (1) JP4826790B2 (en)
KR (1) KR101293893B1 (en)
CN (1) CN101098676B (en)
WO (1) WO2006068001A1 (en)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009155216A (en) * 2007-12-25 2009-07-16 Lion Corp Composition for oral cavity
JP2016199473A (en) * 2015-04-07 2016-12-01 ライオン株式会社 Dentifrice composition and method of inhibiting adsorption of isopropyl methylphenol to container of dentifrice composition
JP2017063756A (en) * 2015-10-01 2017-04-06 株式会社東洋新薬 Composition
JP2017099413A (en) * 2017-03-03 2017-06-08 株式会社東洋新薬 Composition
JP2020196767A (en) * 2015-04-07 2020-12-10 ライオン株式会社 Dentifrice composition and method of inhibiting adsorption of isopropyl methylphenol to container of dentifrice composition
JP2022168043A (en) * 2020-09-14 2022-11-04 ライオン株式会社 Dentifrice composition and method of inhibiting adsorption of isopropyl methylphenol to container of dentifrice composition

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101790809B1 (en) * 2010-03-19 2017-11-20 라이온 가부시키가이샤 Liquid oral composition and method for producing same
CN115040430B (en) * 2022-06-15 2024-03-12 和讯科技(吉林省)集团有限公司 Sun-proof cosmetic containing ebselen and preparation method thereof

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55124793A (en) * 1979-03-22 1980-09-26 Kanebo Ltd Preparation of aqueous solution of silk fibroin peptide
JPS61183298A (en) * 1985-02-07 1986-08-15 Seiwa Kasei:Kk Production of polypeptide for cosmetic
JPS6461412A (en) * 1987-08-31 1989-03-08 Seiwa Kasei Kk Cosmetic composition
JP2000063251A (en) * 1998-08-12 2000-02-29 Lion Corp Composition for oral cavity
JP2001226243A (en) * 2000-02-17 2001-08-21 Lion Corp Composition for oral cavity
JP2001226242A (en) * 2000-02-17 2001-08-21 Lion Corp Composition for oral cavity
JP2001288061A (en) * 2000-04-10 2001-10-16 Lion Corp Composition for oral cavity
JP2002047162A (en) * 2000-08-01 2002-02-12 Asahi Kasei Corp Composition for oral cavity
JP2003113072A (en) * 2001-10-04 2003-04-18 Kanebo Ltd Face scrub

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55124793A (en) * 1979-03-22 1980-09-26 Kanebo Ltd Preparation of aqueous solution of silk fibroin peptide
JPS61183298A (en) * 1985-02-07 1986-08-15 Seiwa Kasei:Kk Production of polypeptide for cosmetic
JPS6461412A (en) * 1987-08-31 1989-03-08 Seiwa Kasei Kk Cosmetic composition
JP2000063251A (en) * 1998-08-12 2000-02-29 Lion Corp Composition for oral cavity
JP2001226243A (en) * 2000-02-17 2001-08-21 Lion Corp Composition for oral cavity
JP2001226242A (en) * 2000-02-17 2001-08-21 Lion Corp Composition for oral cavity
JP2001288061A (en) * 2000-04-10 2001-10-16 Lion Corp Composition for oral cavity
JP2002047162A (en) * 2000-08-01 2002-02-12 Asahi Kasei Corp Composition for oral cavity
JP2003113072A (en) * 2001-10-04 2003-04-18 Kanebo Ltd Face scrub

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2009155216A (en) * 2007-12-25 2009-07-16 Lion Corp Composition for oral cavity
JP2016199473A (en) * 2015-04-07 2016-12-01 ライオン株式会社 Dentifrice composition and method of inhibiting adsorption of isopropyl methylphenol to container of dentifrice composition
JP2020196767A (en) * 2015-04-07 2020-12-10 ライオン株式会社 Dentifrice composition and method of inhibiting adsorption of isopropyl methylphenol to container of dentifrice composition
JP7479254B2 (en) 2015-04-07 2024-05-08 ライオン株式会社 Dentifrice composition and method for inhibiting adsorption of isopropyl methylphenol to a container of a dentifrice composition
JP2017063756A (en) * 2015-10-01 2017-04-06 株式会社東洋新薬 Composition
JP2017099413A (en) * 2017-03-03 2017-06-08 株式会社東洋新薬 Composition
JP2022168043A (en) * 2020-09-14 2022-11-04 ライオン株式会社 Dentifrice composition and method of inhibiting adsorption of isopropyl methylphenol to container of dentifrice composition

Also Published As

Publication number Publication date
KR20070091622A (en) 2007-09-11
JP4826790B2 (en) 2011-11-30
KR101293893B1 (en) 2013-08-06
CN101098676B (en) 2010-12-15
CN101098676A (en) 2008-01-02
JPWO2006068001A1 (en) 2008-06-12

Similar Documents

Publication Publication Date Title
JP4826790B2 (en) Oral composition containing hydrolyzed silk
KR102221531B1 (en) Compositions and methods for dental mineralization
NZ564129A (en) Phosphopeptide or phosphoprotein stabilised amorphous calcium complexes
JP4858681B2 (en) Oral composition and dentin mineral elution suppression method
JP6471667B2 (en) Liquid oral composition
JP2008074774A (en) Oral composition
JP2002047157A (en) Composition for oral cavity
JP5397204B2 (en) Oral composition
JP5035512B2 (en) Oral composition
CN108430922B (en) Mucin-coated silica for bacterial aggregation
JP4697449B2 (en) Tooth whitening composition
JP5709639B2 (en) Oral composition
JP5206938B2 (en) Oral composition
KR101772198B1 (en) Oral care composition and toothpaste for improving tooth health
JP4937583B2 (en) Oral composition
US11617711B2 (en) Compositions and methods for dental care
KR102196459B1 (en) A toothpaste composition with improved antibacterial performance and a toothpaste comprising the composition
JPH10120540A (en) Composition containing biologically active glass for oral cavity
JP4985975B2 (en) Oral composition
EP4331591A1 (en) Water-soluble composition and production method thereof
JPH1067627A (en) Organism active glass-containing composition for oral cavity
CA1290252C (en) Method and compositions for treating dental structures
EP0267994A1 (en) The use of a metal complex for the manufacture of a composition for treating dental structures
Alshoraim Advances in Hard Tissue Remineralization
JPWO2019117211A1 (en) Oral composition

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KM KN KP KR KZ LC LK LR LS LT LU LV LY MA MD MG MK MN MW MX MZ NA NG NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU LV MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2006548846

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 1020077013828

Country of ref document: KR

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 200580046359.1

Country of ref document: CN

122 Ep: pct application non-entry in european phase

Ref document number: 05816784

Country of ref document: EP

Kind code of ref document: A1